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ABSTRACT 
WNT2 AND WNT7B COOPERATIVE SIGNALING IN LUNG DEVELOPMENT 
 
 
Mayumi F. Miller 
 
Edward E. Morrisey, Ph.D. 
 
The development of a complex organ, such as the lung, relies upon precisely controlled 
temporal and spatial expression patterns of signaling pathways for proper specification 
and differentiation of the cell types required to build a lung.  While progress has been 
made in dissecting the network of signaling pathways and the integration of their positive 
and negative feedback mechanisms, there is still much to discover.  For example, the Wnt 
signaling pathway is required for lung specification and growth, but a combinatorial role 
for Wnt ligands has not been investigated.  In this dissertation, I combine mouse genetic 
models and in vitro and ex vivo lung culture assays, to determine a cooperative role for 
Wnt2 and Wnt7b in the developing lung.  This body of work reveals the requirement of 
cooperative signaling between Wnt2 and Wnt7b for smooth muscle development and 
proximal to distal patterning of the lung.  Additional findings reveal a role for the Pdgf 
pathway and homeobox genes in potentiating this cooperation.  In total, these findings 
elucidate how strong bursts of Wnt signaling activity are spatially and temporally 
controlled to affect specific cell populations of the developing lung.       
 iii 
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CHAPTER 1: Introduction 
Summary 
 The development of foregut derived organs relies upon a network of epithelial-
mesenchymal signaling interactions.  The lung, a foregut derived organ, highlights the 
complexity and necessity of this network of signaling pathway interactions.  This 
introductory chapter will discuss lung development, and offer a general overview of 
signaling pathways involved.  The focus will then shift to a specific signaling pathway 
critical to lung development, the Wnt pathway, and the affects global loss of Wnt 
signaling has on specific compartments of the lung.  Next, the roles of specific Wnt 
ligands will be addressed, followed by an introduction to the platelet derived growth 
factor (PDGF) pathway and its role in smooth muscle development, which is affected by 
loss of specific Wnt ligands from the lung.  The goal of this chapter is to introduce the 
reader to the importance of signaling pathway interactions during lung development, and 
the vital role Wnt signaling plays in this process. 
 
Foregut development 
During the blastula stage of development, the early embryo is composed of three 
distinct germ layers – mesoderm, endoderm, and ectoderm.  Following the blastula stage 
is gastrulation, when the endoderm and mesoderm involute, with the endoderm forming 
the gut tube and the mesoderm generating several lineages including bone and skeletal, 
cardiac, and smooth muscle.  The third layer, the ectoderm, encloses the mesoderm and 
will go on to form structures such as the skin and neural organs.   
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Post-gastrulation, the primitive gut endoderm exhibits anterior-posterior (AP) patterning, 
and is highly responsive to paracrine signals. By E7.5, the gut tube is patterned into three 
distinct regions - the foregut, which forms organs including the thyroid, lung, liver, and 
pancreas, the midgut, which forms the small intestine, and the hindgut, which forms the 
large intestine (1).  A gradient of Wnt, fibroblast growth factor (FGF), and bone 
morphogenetic protein (BMP) signaling develops along the AP axis, with highest 
expression of these factors at the posterior hindgut and low to no expression at the 
anterior foregut. For the foregut derived organs to initiate development, interaction 
between the endodermal and mesodermal compartments is necessary.  For example, the 
cardiac mesoderm is required to specify the endoderm to form the liver.  Cardiac cell 
specification begins at E7.5 in the cardiac crescent of the splanchnic mesoderm (2). It is 
this cardiac mesoderm that is vitally important to the specification of the liver in the 
ventral foregut endoderm. FGF signals from the cardiac mesoderm are transmitted to the 
juxtaposed ventral endoderm and without this FGF signal, the liver will not develop (3).   
The capacity of the foregut endoderm to give rise to such a diverse array of 
organs also depends upon tightly coordinated spatial and temporal gene expression.  The 
specification of the lung, at the anterior portion of the ventral foregut endoderm, is 
dependent upon β-catenin mediated Wnt signaling.  Lung agenesis occurs with loss of β-
catenin in the foregut endoderm or loss of Wnt2/2b in the splanchnic mesoderm (4, 5).  
However, at E8.0 Wnt signaling inhibits anterior foregut specification, highlighting the 
dynamic nature of endoderm responsiveness (1).   Therefore, the development of the 
foregut organs involves very tightly controlled spatial and temporal actions of multiple 
signaling pathways.  
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Lung development 
Mouse lung development initiates at embryonic day 9 (E9) with the evagination 
of the anterior portion of the ventral foregut endoderm into the surrounding splanchnic 
mesoderm to form the primitive lung buds.  The dorsal portion of this evagination will 
become the esophagus, while the ventral portion will become the lung.  As development 
proceeds, the lung buds extend to form the two main bronchi of the lung and progress 
through a stereotypic branching process to form the arborized blueprint of the adult lung.  
The terminal portions of the branches then narrow, and begin to form the alveolar 
saccules that will allow for the gas exchange function of the lower airways (6).   
 
Lung endoderm development 
The earliest marker of specified lung endoderm is Nkx2.1, which is expressed in 
the ventral foregut beginning at E9.0 (7).  These Nkx2.1 positive cells are the foundation 
of a diverse array of specialized cell types.  The earliest demarcation of differing cell 
types in the lung begins with the specification of a proximal to distal (P-D) axis, noted by 
the expression of Sox2 in the proximal, non-branching epithelium and Sox9 in the distal 
branching epithelium (8-10).  Of note, Sox2 is also expressed in the esophagus and is 
expressed in a reciprocal pattern to Nkx2.1 (9, 11). The epithelial cells of the lung 
differentiate in the proximal lung first, with the first differentiated cells being the Clara 
cells and ciliated cells, which are specified between E14 – E15.5, and function to protect 
the airways by secreting glycoproteins to capture and remove inhaled particulates (6, 12).  
In the distal epithelium, the alveolar type II cells (AECII) and alveolar type I cells 
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(AECI) begin developing at E16.5 and continue to develop through the perinatal period 
(12).  Interestingly, all epithelial cell types of the lung can be derived from a distal 
endoderm pool of inhibitor of DNA binding 2 (ID2) positive cells until at least E12.5, 
highlighting the plasticity and paracrine influences on cell differentiation during lung 
endoderm development (13).  
 
Lung mesenchyme development 
The precise mechanisms involved in the development of airway and vascular lung 
smooth muscle are as yet unclear.  However, previous studies have shown that the 
mesenchymal cells of the developing lung will form the airway smooth muscle, 
supporting the large airways (parabronchial smooth muscle) and alveoli, and the vascular 
smooth muscle, supporting the endothelium of the developing vascular system.  The 
vascular smooth muscle begins to form in the proximal lung at approximately E12, with 
the mesenchyme condensing to surround endothelial vessels and subsequently 
differentiating into smooth muscle cells (14).  Airway smooth muscle is published to 
form in a similar manner, with distal mesenchymal cells migrating proximally and 
condensing along the epithelial tubes of the developing airways (6).  However, recent 
unpublished work from our lab suggests that airway smooth muscle is derived from the 
cardiogenic second heart field mesenchyme, which migrates to surround the airways.  
Defects in the specification, proliferation, or differentiation of lung smooth muscle can 
lead to multiple pathophysiological conditions, including pulmonary hemorrhage, chronic 
asthma, and pulmonary hypertension. 
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Epithelial – mesenchymal interactions 
Epithelial-mesenchymal interactions are essential for the specification and 
development of the primitive lung.  Tissue recombination studies using explanted E11 
mouse lungs first illustrated the importance of these interactions. If the lung mesenchyme 
is separated from the epithelium prior to culturing, the isolated epithelium cannot branch, 
nor can the cells differentiate.  However, addition of increasing amounts lung 
mesenchyme results in a graded recovery of branching and cell differentiation (15). The 
mesenchyme is not a static tissue, however, and localized signaling interactions occur in 
separate compartments of the developing lung.  When the distal lung mesenchyme is 
attached to the trachea, the normally unbranched tracheal epithelium begins to bud, 
branch, and differentiate into distal lung epithelial cell lineages (16, 17). Conversely, 
when tracheal mesenchyme is grafted to distal lung epithelium, branching is inhibited, 
indicating not only the sufficiency of lung mesenchyme to induce differentiation of lung 
epithelium, but also a proximal-distal spatial specificity of the mesenchymal signal (17).    
 Several factors involved in lung epithelial-mesenchymal interactions have been 
identified, including FGFs, sonic hedgehog (SHH), and Wnts.  Several FGF family 
members are expressed in the developing lung mesenchyme, while their receptors 
(FGFRs) are expressed in the epithelium (18, 19). Mice expressing a dominant negative 
form of FGFR2IIIb, the predominant FGFR in the lung, die in the perinatal period and 
have elongated airway tubes that fail branch (19).  Distal lung formation is absent in 
FGF10 null mutants, but tracheal development proceeds normally, demonstrating a 
requirement of FGFs and their receptors for lung branching (20).   Shh is expressed 
throughout the lung endoderm, but most highly expressed at the distal lung bud tips, 
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while the surrounding mesenchyme is enriched for the Shh receptor, Patched (Ptc) (21).  
The Shh-/- mutant has incomplete septation of the trachea and esophagus, decreased lobe 
number, and defective branching morphogenesis (22).  Multiple Wnt ligands are 
expressed during lung development, and later in this chapter, I will discuss the necessity 
of Wnt signaling for lung development. Wnt2 is expressed in the developing 
mesenchyme, Wnt7b expressed in the developing epithelium, and Wnt5a and Wnt11 are 
expressed in both compartments (4, 23, 24).  The mutants for Wnt2, Wnt5a, and Wnt7b 
have severe lung defects, and will also be discussed later in this chapter.   
 
Signaling pathways involved in lung development - branching 
 Nkx2.1, which is the earliest known marker of lung specification, is a 
homeodomain transcription factor expressed throughout the endoderm in early lung 
development. However, as development proceeds, expression becomes confined to the 
distal epithelium.  The Nkx2.1-/- lung consists of two unbranched, sac-like cysts distal to 
the main stem bronchi, with defective specification of distal epithelial cells.  A possible 
component of the mechanism for the severe branching defect may be the near absence of 
Bmp4 expression in Nkx2.1-/- lungs, as Bmp4 is involved in lung bud branching and 
outgrowth (11, 25).     
Branching of the lung airways requires epithelial-mesenchymal interactions.  Loss 
of endodermally expressed Shh leads to defective branching, increased endodermal 
Bmp4 expression and expanded mesodermal Fgf10 expression (22).  Meanwhile, 
overexpression of Shh in the lungs results in decreased Fgf10 expression (18).  Bmp4 
expression in the developing endoderm is normally restricted to the distal bud tips and a 
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cleft forms in the area of low Bmp4 expression to allow for the bud to bifurcate (26).  
Fgf10 is expressed in the mesenchyme surrounding the distal endoderm buds, with 
highest expression where the lung bud will branch and elongate, and low expression at 
the cleft (18).  Lung explant cultures show that Fgf10 is a chemoattractant for 
endodermal cells and that Bmp4 expression is initiated when Fgf10 is in proximity to the 
endoderm (26). These feedback mechanisms can be put together to provide a node of 
branching morphogenesis (Figure 1.2).  Shh in the distal endoderm inhibits mesenchymal 
Fgf10 expression at the distal point of the bud, which will become the cleft of the 
branching bud.  Fgf10 in the mesenchyme on either side of the nascent bifurcating bud 
upregulates Bmp4 expression on the lateral sides of the bud, causing it to bifurcate.  This 
Bmp4 expression causes outgrowth of the branch points towards the two points of highest 
Fgf10 expression (22, 26).  Therefore, the growth and branching defects in the Shh-/- 
lung can be partially explained by the loss of distinct Bmp4 and Fgf10 expression 
patterns, mediated by the initial Shh signal, necessary to specify the branch point by 
negatively regulating Fgf10.  The signaling pathways involved in branching, though, do 
not necessarily affect patterning of the lung epithelium, as even with the severe branching 
defects in the Shh-/- lungs, proximal to distal patterning of the endoderm is normal (22). 
 
Signaling pathways involved in lung development – proximal and distal patterning 
 The precise mechanisms of P-D patterning are still under study, and the feedback 
loops that exist can occasionally obscure the initiating signal, but multiple knockout and 
transgenic overexpression models provide an approximate understanding of P-D lung 
patterning.  In addition to Bmp’s role in branching morphogenesis, Bmp signaling is also 
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important for the development of the P-D axis of the lung.  When the Bmp receptors, 
Bmpr1a and Bmpr1b, are conditionally deleted from the lung endoderm, the trachea fails 
to form, and the two main bronchi of the lung grow out from the esophagus.  In these 
mutant lungs, Nkx2.1 is initially expressed in the ventral foregut endoderm, but Nkx2.1 
expression is not maintained, and Sox2 expression, in the dorsal endoderm, which 
denotes the esophagus, expands.  Bmp has a role in repressing esophageal fate in the 
foregut by repressing the Sox2 promoter, and with the loss of Bmpr1a and Bmpr1b, Sox2 
is not repressed, and the trachea does not form (27).  Interestingly, the bronchi of the 
lungs do form, and branching, though defective, does occur.  The proximal to distal 
patterning of the lung is abnormal, as there is a significant reduction in the proportion of 
distal cell types (27). One hypothesis for the ability of the lung to develop directly from 
the esophagus is that the bronchi of the lungs elongate into the lung mesenchyme, and the 
mesenchyme is able to maintain lung identity in the bronchi, which further supports the 
importance of epithelial mesenchymal interactions (27).       
Foxa1 and Foxa2, transcription factors containing winged helix DNA binding 
domains, are expressed in the epithelial cells of the developing lung. While deletion of 
Foxa1 does not have a reported lung phenotype, loss of Foxa2 in epithelial cells leads to 
increased goblet cells in the proximal airways, and defects in the formation of the alveoli 
of the lung postnatally (28-30).  Combined loss of Foxa1 and Foxa2 results in a much 
more severe phenotype than either single mutant, as Foxa1-/-;Foxa2-/- lungs have smooth 
muscle and epithelial cell differentiation defects.  The lungs lack expression of markers 
for the ciliated and Clara cells of the upper airways and the AECII cells of the lower 
airways (31).  Foxa1 and Foxa2 function upstream of Shh, and Foxa2 binds to and 
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activates the Wnt7b promoter (32).  Foxa1/2 regulation of Shh and Wnt7b may explain 
the smooth muscle phenotype in the Foxa1-/-;Foxa2-/- lungs, as both Shh and Wnt7b 
signal to the mesenchyme, and mutants of both have smooth muscle defects (22, 23, 31, 
33).  
GATA6, a zinc finger transcription factor, is expressed in the epithelium of the 
developing lung and is also important for development of the distal lung epithelium.  
Deletion of GATA6 in the lung epithelium results in defective epithelial cell 
development, and also results in ectopic expression of Clara cells in the distal airways 
(34).  An interesting phenotype of the GATA6 deletion is an increase in bronchioalveolar 
stem cells (BASC), which are thought to function as a progenitor cell in the lung.  The 
increased abundance of BASCs, at the loss of differentiated epithelial cells, demonstrates 
the importance of GATA6 in cell differentiation. GATA6 functions by increasing non-
canonical Wnt signaling in the lung to decrease canonical signaling, as the two Wnt 
pathways can antagonize each other.  Therefore, this work also highlights a role for Wnt 
signaling in cell differentiation (34, 35).  
 
Signaling pathways involved in lung development – smooth muscle 
 The Wnt pathway is important for lung endoderm development, but also plays an 
important role in lung smooth muscle development. Though the precise mechanisms are 
as yet unknown, there is strong evidence in the literature that Fgf and Wnt signaling work 
in concert to regulate mesenchymal proliferation and subsequent differentiation.  Fgf9 is 
expressed in a dynamic pattern during early lung development, with expression in both 
the mesothelium (pleural lining surrounding the lung) and lung endoderm until E12.5, 
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when expression becomes restricted to the mesothelium (36).  The Fgf9-/- lungs are 
hypoplastic in both the epithelial and mesenchymal compartments and have reduced 
branching with dilated distal tips, but P-D epithelial development is comparable to 
control lungs (37). Conditional deletion of Fgf9 in either the mesothelium or the 
endoderm reveals a dual role for Fgf9.  Mesothelial expression serves to maintain 
mesenchymal cell proliferation, while endodermal expression maintains endodermal cell 
proliferation (38).  Explant studies have shown that Fgf9 prevents mesenchymal cell 
differentiation into smooth muscle, which may explain why loss of Fgf9 results in 
hypoplastic mesenchyme, as it may have prematurely differentiated without proliferating 
(39). Fgf9 also plays an important role in potentiating mesenchymal Wnt2 expression, as 
loss of Fgf9 results in absence of Wnt2 by E12.5, but overexpression results in increased 
Wnt2 expression (40).  Wnt2 is required for proper smooth muscle development and has 
a regulatory role over Fgf10.  As mentioned previously, Fgf10 works in concert with 
Bmp4 and Shh to regulate epithelial branching, which may be the cause of the Fgf9-/- 
lung branching defects (4, 22, 26).  The early events of lung development highlight the 
cross-regulation that occurs among multiple signaling pathways to coordinate lung 
development.  The next section of this chapter will discuss the Wnt pathway, which has 
multiple functions in the lung including specification, P-D cell differentiation, and 
smooth muscle development.      
 
Discovery of Wnt pathway 
In 1980, Christiane Nusslein-Volhard and Eric Wieschaus discovered the 
Wingless (wg) gene in drosophila, which controls segment polarity, while in 1982 Roel 
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Nusse and Harold Varmus discovered a mutation in the int-1 gene that results in mouse 
mammary tumors (41).  In 1987, the drosophila wg gene was found to be identical to the 
murine int-1 gene, and by 1990, the nomenclature of wg/int signaling combined to 
become Wnt signaling (42, 43). 
 
Canonical and non-canonical Wnt signaling 
Wnt proteins are characterized by twenty-two highly conserved cysteine residues 
and are post-translationally modified by glycosylation and acetylation prior to cell 
secretion.  When Wnt signaling is inactive, cytoplasmic β-catenin interacts with a 
complex of proteins including adenomatous polyposis coli (APC), glycogen synthase 
kinase 3β (GSK3β), Axin, and casein kinase 1α (Ck1α).  In this complex, Ck1α 
phosphorylates β-catenin on Ser-45, followed by GSK3 phosphorylation on Ser33, Ser37, 
and Thr41, resulting in recognition of β-catenin by β-transducin repeat containing protein 
(βTrcp), which then mediates ubiquitin mediated proteolysis of β-catenin (44-46).  
Wnt signaling is commonly delineated into two categories: canonical (β-catenin 
dependent) and non-canonical (non-β-catenin dependent).  In the canonical pathway, 
secreted Wnt proteins bind to the Fzd/LRP co-receptor, resulting in Disheveled (Dsh) 
binding to Fzd and causing dissociation of GSK-3β, Axin, and APC.  β-catenin is then 
free to accumulate in the cytoplasm and translocate to the nucleus.  Once in the nucleus, 
β-catenin interacts with the LEF/TCF DNA binding proteins to activate gene expression, 
as β-catenin does not have a DNA binding domain (Fig 1.3) (47, 48). Non-canonical 
signaling is more divergent and not as clearly understood.  It can be divided into at least 
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two additional signaling pathways: the Wnt/Ca2+ pathway and the Wnt/Rho/JNK 
pathway.  In the Wnt/Ca2+ pathway, Wnt signaling modulates the activity of 
Ca2+/Calmodulin-dependent protein kinase II (CamKII) and PKC, through Fzd proteins 
in a heterotrimeric G-protein dependent manner (49, 50).  In the Wnt/Rho/JNK pathway, 
Wnt signaling affects cell polarity and movement through the activity of Rho/Rho-
associated Kinase (ROK) and Jun-N-terminal kinase (JNK) (51, 52).  Non-canonical Wnt 
signaling inhibits the canonical pathway in many contexts, suggesting a possible 
regulatory function between different Wnt proteins and their downstream signaling 
components (35).  
Of note, whether a Wnt ligand will activate the canonical or non-canonical 
pathway cannot be determined by protein sequence or structure.  Also, depending upon 
receptor availability and context, Wnt ligands can activate both the canonical and non-
canonical pathways, (53).  For example, Wnt5a activates the canonical pathway by 
binding to the Fzd4 receptor, whereas signaling through the alternate Ror2 receptor 
activates the non-canonical pathway (54).  In Xenopus, Wnt11 signals canonically in the 
developing embryo to regulate axis specification, but signals non-canonically in heart 
development to inhibit β-catenin signaling (55, 56).    
 
Wnt signaling in the lung  
 To determine if Wnt signaling plays a role in lung development, Wnt signaling 
was visualized using three transgenic mouse lines – BATGAL, TOPGAL, and Axin2LacZ 
(57-59).  The BATGAL transgenic reporter mouse has seven TCF/LEF binding sites 
upstream of the Xenopus siamois minimal promoter, which drives the expression of β-
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galactosidase in the nucleus (58).  The TOPGAL transgenic reporter mouse has three 
TCF/LEF sites upstream of the c-fos minimal promoter, driving expression of β-
galactosidase in the cytoplasm (57).  The Axin2LacZ knock-in reporter mouse utilizes a 
different approach, as Axin2 is a target of canonical Wnt signaling, and therefore the 
Axin2LacZ mouse is a reporter of endogenous Wnt signaling activity (59).  The 
visualization of these reporter lines in the developing lung show that canonical Wnt 
signaling is active from the point of lung specification at E9.5 in the ventral foregut (60).  
Because each reporter line is unique in its construction, there are differences in the Wnt 
signaling expression patterns in the lung.  At E11.5 the BATGAL reporter strain shows 
Wnt signaling in punctate locations throughout the lung epithelium, and by E13.5, there 
is reporter activity in the mesenchyme adjacent to the proximal non-branching airways.  
As development proceeds through E18.5, expression is reduced, but punctate regions of 
BATGAL activity are maintained in the distal airways and upper airway smooth muscle 
(58, 59, 61).  The TOPGAL reporter strain shows β-catenin signaling in the lung 
endoderm beginning at E9.5, and then from E11.5-E12.5, expression becomes more 
concentrated in the distal epithelium.  From E15.5 to birth, TOPGAL expression becomes 
progressively restricted to the proximal airways (60).  The Axin2LacZ reporter shows Wnt 
activity in the ventral foregut endoderm at E9.25, but not in the dorsal endoderm that will 
form the esophagus (5).  By E11.5 Axin2LacZ is expressed throughout the lung endoderm 
and at lower levels in the mesenchyme.  By E13.5, expression is in the distal airways and 
proximal airway smooth muscle, and from E16.5 until birth, there is signaling throughout 
the airways and adjacent mesenchyme (59).  While each of these reporter lines has their 
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strengths and weaknesses, all three clearly show the dynamic expression of Wnt signaling 
throughout lung development. 
 
Wnt signaling - lung endoderm 
 Since we know Wnt signaling is active in the developing lung, the next question 
to address is the functional role of Wnt signaling during lung development. Genetic 
deletion of β-catenin allows for the dissection of temporally and spatially specific roles of 
β-catenin in the lung.  When β-catenin is deleted from the lung endoderm early in 
development, at approximately E10.5, there are profound defects in the specification of 
the distal epithelium of the lung, which result in a proximalized lung phenotype.  
However, when β-catenin is deleted later in lung development (E14.5), the lung develops 
normally (62).   
 Since β-catenin also has a role in cytoskeletal stability, Shu et al. employed a 
different method to decrease canonical Wnt signaling in the developing lung endoderm, 
without structurally affecting β-catenin (61, 63).  Dikkopf-1 (Dkk1) is a negative 
regulator of Wnt signaling, binding to LRP5/6 and preventing the formation of a 
Fzd/Wnt/LRP signaling complex (64, 65).   Overexpression of Dkk1 in the lung 
endoderm beginning at E10.5 results in a similar phenotype as the early β-catenin 
deletion, confirming the early loss of β-catenin phenotype as Wnt specific (61).    
 When β-catenin is deleted from the foregut endoderm prior to lung specification, 
Nkx2.1 positive lung endoderm progenitors are not specified, but other endodermally 
derived organs are specified (4, 5).  Interestingly, if β-catenin is overexpressed in the 
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foregut endoderm, prior to lung formation, the proximal stomach expresses the lung 
restricted marker Nkx2.1, illustrating the ability of β-catenin to ectopically specify lung 
fate (4, 5, 66).  
 
Wnt signaling - lung mesenchyme  
 Two approaches have been taken to delete Wnt signaling in the lung 
mesenchyme.  The first approach is a global deletion of β-catenin from the lung 
mesenchyme, resulting in hypoplastic lungs, with decreased epithelial branching and 
reduced mesenchyme (40, 66, 67). By E14.5, lung growth is halted and the trachea begins 
to degenerate.  By E18.5, the terminal airways are not developed, and mice harboring this 
mutation are perinatal lethal (40, 66).  
 The second approach specifically deletes β-catenin in the vascular and airway 
smooth muscle (33, 68).  The results of this experiment clearly demonstrate that smooth 
muscle development in the lung is dependent upon Wnt signaling, as there are fewer 
smooth muscle precursor cells, and subsequently a thinner smooth muscle layer 
surrounding the airways and vasculature when compared to control (33).  Lithium 
chloride injections can increase β-catenin signaling by inhibiting GSK3β, thereby 
increasing the available β-catenin in the cytoplasm (69).  If the Wnt pathway is 
exogenously activated during embryogenesis, through LiCl injections to pregnant dams, 
the smooth muscle progenitor cells in the lung increase in number, resulting in a thicker 
smooth muscle layer surrounding the airways and vasculature, compared to controls (33).  
 
Expression of Wnt ligands in the lung 
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 There are at least four Wnt ligand families expressed in the developing lung, 
Wnt2, Wnt5, Wnt7, and Wnt11 (4, 23, 24, 32, 70).  Wnt11 is broadly expressed in both 
the mesenchymal and epithelial compartments of the lung, and no lung phenotype has 
been reported in Wnt11 mutants (32).  Wnt5a is expressed in both the mesenchymal and 
epithelial compartments of the lung, with higher expression in the distal branching tips 
beginning at E16.5 (24).  In Wnt5a-/- mutants, the lungs are larger than control lungs, and 
have increased branching and overgrowth of the distal compartments (24).  Shh, Fgf10, 
and Bmp4 expression is increased in these mutants, which may partly explain the 
branching defects, as previously described in this chapter.   Overexpression of Wnt5a in 
the endoderm results in hypoplastic lungs with decreased branching and dilated distal 
airways (71).  Shh expression is decreased, and Bmp4 expression, while not 
quantitatively different, becomes more broadly expressed (71). 
Wnt2 expression is restricted to the lung mesenchyme, with higher expression in 
the distal lung mesenchyme (32, 72).  Wnt2-/- mutants are 80% perinatal lethal and have 
hypoplastic lungs (4, 73).  Upon closer inspection, the Wnt2-/- lungs have thinned airway 
smooth muscle, but normal vascular smooth muscle development (74).   Further work has 
shown that loss of Wnt2 results in decreased expression of the smooth muscle progenitor 
marker, PDGFR-β, as well as smooth muscle transcription factors myocardin and Mrtf-B 
(74). 
Wnt7b is expressed throughout the developing lung epithelium. There are two 
reported Wnt7b mutant alleles, the Wnt7bLacZ, which has the coding sequence of the first 
exon of Wnt7b replaced with the LacZ gene, and the Wnt7bC3, which has loxP sites 
flanking the third exon of Wnt7b (23, 75).  The Wnt7b gene has two isoforms, with two 
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distinct first exons and ATG start sites (75).  As such, the Wnt7bLacZ mouse strain most 
likely functions as a potent hypomorph, as the alternate first exon is not disrupted by the 
insertion of the LacZ allele (23).  Of note, the Wnt7bLacZ has robust knockdown of the 
Wnt7b transcript, with a 90% decrease in Wnt7b transcript levels compared to control 
lungs (33). The Wnt7b mutant alleles result in perinatal lethality and have severely 
hypoplastic lungs with defects in AECI development (23, 75).  The Wnt7bLacZ mutant 
also has airway and vascular smooth muscle defects (23).  The smooth muscle phenotype 
in the Wnt7bLacZ mutant lungs is attributed to an indirect effect on PDGF signaling (33).  
Expression of Wnt7b in Pac1 cells, a vascular smooth muscle cell line, results in 
increased Tenascin C (Tnc) expression.  Expression of Tnc protein in Pac1 cells results in 
increased PDGFR-β expression and the use of Tnc blocking antibodies in lung explants 
results in decreased PDGFR-β expression, suggesting Wnt7b has an indirect role in 
PDGFR-β expression (33).  Of note, the Wnt2 and Wnt7b mutant lungs have very similar 
phenotypes, and the ligands are expressed in complementary patterns during lung 
development.  Knowing the importance of epithelial and mesenchymal interactions 
during development, the question arises as to whether Wnt2 and Wnt7b interact. 
 
The PDGF pathway 
 The PDGF signaling pathway utilizes receptor tyrosine kinases to activate 
downstream transcriptional events. There are four PDGF ligands (PDGF-A, PDGF-B, 
PDGF-C, and PDGF-D) and two receptors (PDGFR-α and PDGFR-β).  The focus of my 
work will be on PDGF-A and PDGF-B.  The PDGF ligands bind to the PDGFR’s as 
homo- and heterodimers.  Only the PDGF-B ligands can bind to PDGFR-β, but PDGF-
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AA, PDGF-AB, and PDGF-BB can bind to PDGFR-α.  Because signaling occurs through 
ligand dimers, when the ligands bind, two receptors are brought into close apposition and 
autophosophorylation events occur between intracellular tyrosines on the two receptors, 
activating multiple signaling pathways, including Ras-MAPK, PI3K, and PLCγ (76, 77).  
Of note, unique kinase sites on the cytosolic side of the receptor activate different 
downstream pathways (78, 79). 
 PDGF signaling plays an important role in smooth muscle formation during 
embryogenesis.  PDGF-A is expressed in the developing lung epithelium, with 
expression decreasing by E18.5, while PDGFR-α is expressed in the developing 
mesenchyme directly adjacent to the epithelium (80).  PDGF-A-/- mice are viable and 
have an emphysema like phenotype.  They have dilated lower airways with poor alveolar 
air sac formation and loss of supporting myofibroblasts, leading to atelectasis.  However, 
only the smooth muscle formation in the lower airways is defective, as vascular and 
parabronchial smooth muscle development is normal (80).  Overexpression of PDGF-A 
in the lung endoderm results in overgrowth of the lung, with mesenchymal thickening to 
such an extent that sacculation of the lower airways is inhibited (81).  These two mouse 
models highlight the potent affect PDGF-A has on mesenchymal proliferation and distal 
airway and smooth muscle development. 
 PDGF-B is expressed in vascular endothelial cells, while PDGFR-β is expressed 
on pericytes and developing smooth muscle cells (82).  Mouse mutants for both of these 
genes exist, and have similar phenotypes.  The PDGF-B-/- mice are born with obvious 
subcutaneous hemorrhaging, heart and kidney defects, and hematological disorders 
including anemia and immature blood cell development (83).  The PDGFR-β-/- mice are 
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born with subcutaneous hemorrhaging, kidney defects, and hematological disorders (84). 
Further work in the field has lead to an understanding of PDGF’s role in angiogenesis. 
PDGF-B expressed in endothelial cells of developing vessels attract, and cause the 
proliferation of, PDGFR-β expressing smooth muscle cells to increase the integrity of the 
growing blood vessels.  The hemorrhagic phenotype of the PDGF-B-/- and PDGFR-β-/- 
mice may result from rupture of weakened vessels that do not have the increased integrity 
smooth muscle support confers (85). 
 
Wnt interactions with the PDGF pathway 
 Roles for the PDGF pathway and the Wnt signaling pathway in vascular smooth 
muscle development have been established (76, 86, 87).  However, a more recent 
paradigm illustrates an interaction between the Wnt and PDGF pathways that affects 
smooth muscle cell proliferation and differentiation.  As mentioned previously, there is a 
decrease in the expression of PDGFR-β in the Wnt2-/- lung and the Wnt7b-/- lung, 
however a direct role for Wnt signaling in PDGFR-β expression levels was not addressed 
in either study (33, 74).  Recent evidence suggests that the Wnt pathway can directly 
regulate the expression of PDGF ligands and that downstream components of the PDGF 
pathway mediate the effects of Wnt signaling (88, 89). 
 Work in glioblastoma and endothelial cell lines show that Wnt1 and Wnt3a can 
regulate the expression of PDGF-B directly, as β-catenin activation domain-Lef1 DNA 
binding domain fusion constructs increase both the transcription and translation of 
PDGF-B (88).  Following injury, VSMC proliferation and vessel wall thickening occurs 
in conjunction with increased Wnt signaling.  To illustrate a requirement for Wnt 
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signaling in VSMC proliferation, explant cultures of dissected aortas were treated with 
PDGF-BB to increase VSMC proliferation.  However, if the explants are also treated 
with Dkk1 or siRNA against Wnt4a, there is a significant decrease in PDGF-BB 
mediated VSMC proliferation (64, 89).  In human mesenchymal stem cells and 
preosteoblastic cell lines, which are of mesenchymal origin, Wnt3a increases cell 
proliferation through the transient activation of PDGFRs, as measured by receptor 
phosphorylation (90).  In this context, Wnt3a signals non-canonically, and decreasing 
PDGF signaling through the use of PDGFR inhibitors or PDGFR-β siRNA, blocks the 
affect of Wnt3a on cell proliferation (90).  These studies provide evidence that Wnt 
signaling and the PDGF pathway cooperate to regulate smooth muscle proliferation, and 
by extension, smooth muscle development. 
 21 
 
 
 
 22 
 
Figure 1.1 Mouse lung development 
(A) At E9.5 the ventral foregut endoderm evaginates into the surrounding mesenchyme to 
form the primitive lung bug.  The LacZ staining in the lung and hindbrain show the 
expression of Wnt7b at this time point. (B) At E10.5, the bronchi of the lungs extend into 
the mesenchyme, and by (C) E11.5, the stereotyped branching of the lung has initiated. 
(D) At E13.5, the arborized blueprint of the lung has formed, and as development 
proceeds through E16.5, (E) epithelial cells in the proximal airways such as ciliated cells, 
Clara cells, and goblet cells, will become specified.  (F) By E18.5, the terminal airways 
have begun to form alveoli, and AECII and AECI become specified and continue to 
develop throughout the perinatal period. 
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Figure 1.2 Illustration of BMP4, FGF, and SHH interactions for lung bud branching 
(A) The branching distal endoderm expresses SHH and BMP4, while the distal 
mesenchyme adjacent to the branching endoderm expresses FGF.  (B) SHH down 
regulates FGF signaling at the tip of the branching bud, creating a zone of decreased FGF 
signaling.  BMP4 expression is induced by the two FGF signaling centers, and the 
endoderm extends toward the FGF source, causing a cleft at the SHH high, FGF low 
zone.   
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Figure 1.3 Canonical Wnt signaling pathway 
(A) When Wnt signaling is not active, β-catenin is bound to a complex of proteins 
including APC, Axin, and GSK3 and phosphorylated to mark β-catenin for ubiquitin 
mediated proteolysis.  Lef/Tcf signaling does not occur.  (B) When a Wnt ligand binds to 
the Fzd/LRP5/6 receptor complex, Dsh causes the disruption of the APC, Axin, GSK3 
complex, and β-catenin accumulates in the cytoplasm and then translocates to the nucleus 
to bind Lef/Tcf factors and activate target gene transcription. 
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CHAPTER 2: Subsets of Wnt ligands signal in a cooperative manner through the 
PDGF pathway to promote foregut organogenesis 
A portion of this chapter is published in: Proc Natl Acad Sci (Miller et al. 2012) 
 
Summary 
In Chapter 1, I highlighted the importance of epithelial-mesenchymal signaling in the 
lung, described some of the signaling pathways involved in lung development, and 
offered a brief overview of the signaling crosstalk that occurs.  I also introduced Wnt2 
and Wnt7b as complementarily expressed Wnt ligands in the lung, which have very 
similar mutant phenotypes. In this chapter, I am going to address an outstanding question 
in the Wnt and lung fields concerning Wnt ligand crosstalk, and also address the 
combinatorial role of Wnt2 and Wnt7b during lung development.  I show that Wnt2 and 
Wnt7b cooperate in mesenchymal cells to potentiate high levels of canonical signaling, 
important for P-D endoderm patterning and smooth muscle development.  I also show 
that the level of signaling cannot be explained by increased β-catenin accumulation, and 
therefore utilize a high throughput chemical screen to identify the PDGF pathway’s 
capacity to influence Wnt signaling. 
 
Introduction 
As mentioned in Chapter 1, distinct regions of the foregut endoderm are specified 
to become the lung, liver, stomach, pancreas, and thyroid.  The capacity of the foregut 
endoderm to develop into these organs is mediated in part through reciprocal signaling 
interactions with the adjacent mesenchyme (15, 17).  One signaling pathway of note is 
the Wnt pathway, with Wnt ligands expressed in spatially specific patterns along the 
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anterior-posterior axis of the developing gut tube in both the developing endodermal and 
mesenchymal components.  One goal of this chapter is to add to the understanding of 
how Wnt expression functions to promote regionally specific foregut development.  
The anterior aspect of the foregut endoderm is surrounded by the splanchnic 
mesoderm, which expresses Wnt2, and Wnt2-/- mutant mice have hypoplastic lungs with 
defective airway smooth muscle development. Of note, combined loss with Wnt2b results 
in lung agenesis (4, 5). Wnt7b is expressed in the developing lung endoderm, and Wnt7b-
/- mice also have hypoplastic lungs with defective airway smooth muscle development, 
along with defective vascular smooth muscle development (23, 75). The importance of 
epithelial-mesenchymal interactions was highlighted in Chapter 1, and one goal of this 
chapter is to determine if two families of Wnt ligands, Wnt2 and Wnt7, cooperate to 
promote lung development.  A recent study has shown two Wnt ligands, Wnt5a and 
Wnt11, can interact and cooperate to promote Xenopus axis formation, supporting our 
hypothesis that specific Wnt ligand interactions may promote important aspects of 
vertebrate development (91). 
Given the complementary expression patterns of Wnt2 and Wnt7b and the 
previous findings that genetic inactivation of either Wnt2 or Wnt7b leads to a similar 
hypoplastic lung phenotype with defects in smooth muscle development (4, 23, 33, 74, 
75), we sought to determine whether context dependent Wnt autocrine and paracrine 
signals active in the developing anterior foregut cooperate to promote development of the 
lung.  In this Chapter, I show that Wnt2 and Wnt7b cooperate to drive high levels of Wnt 
signaling activity specifically in mesenchymal cells, with cell type specificity mediated 
through Fzd receptor availability.  Through the use of a high throughput small molecule 
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screens, I then identify the PDGF pathway as necessary and sufficient to promote the 
cooperation between Wnt2 and Wnt7b.  Taken together, these studies define a novel 
mechanism whereby specific Wnt ligands cooperate to promote high levels of signaling 
in a cell lineage specific manner, in part through PDGF signaling. This mechanism 
illustrates how combinations of Wnt ligands can confer spatial and temporal canonical 
Wnt regulation of foregut organogenesis. 
 
RESULTS 
Wnt2 and Wnt7b are expressed in a complementary fashion in the lung 
Previous work has shown Wnt2 and Wnt7b are expressed in mutually exclusive 
domains in the developing anterior foregut and lung (4, 23). We performed in situ 
hybridization and utilized the LacZ knock-in to the Wnt7b allele to visualize the 
expression patterns of Wnt2 and Wnt7b in the developing lung from E9.5-E11.5.  Wnt2 
expression is observed in the mesenchyme on the ventral side of the anterior foregut at 
E9.5 (Fig. 2.1A). At this same time point, Wnt7b is expressed exclusively in the ventral 
anterior foregut endoderm where the lung endoderm progenitors are specified (Fig. 2.1B). 
This complementary expression pattern with Wnt2 expressed in the developing 
mesenchyme and Wnt7b expression restricted to the developing lung endoderm continues 
at E10.5 and E11.5 (Fig. 2.1C-F).  In Chapter 1, I introduced that signaling pathways in 
close proximity work to cross regulate specific developmental programs, and the 
expression patterns of Wnt2 And Wnt7b suggest that they may also interact.  
 
Specific subfamilies of Wnt ligands drive cooperative signaling activation 
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To test whether Wnt2 and Wnt7b can cooperate to promote Wnt signaling, we 
transfected the rat lung mesenchymal cell line, RFL6, with expression plasmids for Wnt2 
and Wnt7b, alone or in combination, along with the SuperTopFlash (STF) reporter, to 
detect canonical Wnt signaling activity.  The STF reporter consists of 7 repeated Lef/Tcf 
binding sites preceding a firefly luciferase gene (92).  While either Wnt2 or Wnt7b 
expression alone results in reproducible but low-level STF activation, the combination of 
Wnt2 and Wnt7b results in a dramatic cooperative activation of STF (Fig. 2.2A). To 
determine whether Wnt2 and Wnt7b can also activate an endogenous target of Wnt 
signaling in a cooperative manner, we assessed expression of endogenous axin2, a well 
described direct target of Wnt signaling, using quantitative PCR (Q-PCR) (93). These 
data show that Wnt2 and Wnt7b can activate endogenous axin2 in a cooperative manner 
in RFL6 cells (Fig. 2.2B).  
To determine whether the cooperative Wnt activation by Wnt2 and Wnt7b is 
specific to these ligands, we tested whether Wnt1, a traditionally canonical Wnt ligand, or 
Wnt5a, a traditionally non-canonical Wnt ligand, could cooperate with Wnt2 or Wnt7b 
(94, 95). Our studies show that neither Wnt1 nor Wnt5a cause cooperative activation of 
Wnt signaling with Wnt2 or Wnt7b (Fig. 2.2C,D).  However, Wnt2b and Wnt7a are able 
to cooperatively activate STF, indicating that members of the Wnt2 and Wnt7 families 
are capable of cooperation (Figure 2.2E,F).  
To determine if either Wnt2 or Wnt7b could cooperate in the presence of a 
constitutively active β-catenin, we expressed a stable form of activated β-catenin (ABC) 
containing point mutations that prevent its degradation, along with either Wnt2 or Wnt7b 
(96). Expression of ABC along with either Wnt2 or Wnt7b did not result in the 
 31 
cooperative effect observed between Wnt2 and Wnt7b (Fig. 2.2G). However, ABC did 
potentiate Wnt7b signaling, suggesting that Wnt7b may act to enhance canonical Wnt 
pathway activation.  But, this potentiation was multiple folds lower than the Wnt2 and 
Wnt7b cooperation (Fig. 2.2H). These data suggest that Wnt2/Wnt7b signaling 
cooperation involves a mechanism distinct from simple activation of the β-catenin 
dependent canonical pathway. 
 
Wnt2/Wnt7b cooperative signaling is essential for early lung development 
To determine if the in vitro cooperation observed between Wnt2 and Wnt7b plays 
a significant role in vivo, we determined the consequences of Wnt2 and Wnt7b deletion 
during early lung development.   As described in Chapter 1, loss of either Wnt2 or Wnt7b 
alone results in a similar lung hypoplasia and decreased smooth muscle phenotype (4, 23, 
74, 75). Wnt2-/-;Wnt7b-/- double mutant lungs show severe defects in branching 
morphogenesis with an almost complete loss of secondary branching after trachea 
separation from the esophagus (Fig. 2.3A-J). Because the Wnt2-/-;Wnt7b-/- mutants die 
by E13.5, our analysis is restricted to E12.5 and earlier (data not shown). Although 
trachea-esophagus separation is apparent in the histological sections of Wnt2-/-;Wnt7b-/- 
double mutants at all time points tested, we assessed expression of Nkx2.1 and p63, 
markers of lung and esophagus endoderm respectively, to determine whether there were 
defects in early specification of lung endoderm. Expression of Nkx2.1 is restricted to the 
developing trachea while expression of p63 is restricted to the developing esophagus in 
both control and Wnt2-/-;Wnt7b-/- mutants (Fig. 2.3K-N) (7, 97). Thus, while loss of 
Wnt2 or Wnt7b alone leads to a minor lung hypoplasia phenotype, the combined loss of 
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both Wnt2 and Wnt7b leads to a dramatic loss of lung branching morphogenesis but 
normal lung endoderm specification (23, 74).  
 
Wnt2/Wnt7b cooperation is required for development of distal lung endoderm 
progenitors 
Given the significant defects in early branching of the lung, we examined whether 
there were alterations in proximal and distal progenitor development in the Wnt2-/-
;Wnt7b-/- mutants.  As stated in Chapter 1, deletion of β-catenin in the developing lung 
mesenchyme or endoderm results in defective distal epithelial cell development, leading 
us to hypothesize that we may also observe defects in P-D epithelial cell development 
(40, 62).  We assessed expression of Sox2, a marker of proximal endoderm progenitors, 
and Sox9, a marker of distal endoderm progenitors, in E11.5 lungs using immunostaining 
(98, 99). While Sox2 is confined to the proximal regions of the developing airway 
branches as well as the esophagus in both Wnt2+/-:Wnt7b+/- controls and Wnt2-/-
;Wnt7b-/- double mutants (Fig. 2.4A-D), Sox9 expression is expressed at low levels and 
diffusely throughout the defective airways in the Wnt2-/-;Wnt7b-/- mutants and does not 
exhibit the polarized expression pattern apparent in the control lungs (Fig. 2.4E-H). 
These data suggest that P-D patterning of the lung endoderm progenitors is disrupted in 
Wnt2-/-;Wnt7b-/- mutants.   
 
Wnt2/Wnt7b cooperation is required for smooth muscle development 
As described in Chapter 1, epithelial-mesenchymal signaling is essential for 
development of lung mesodermal derivatives such as airway smooth muscle (6). Given 
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the defects in P-D endoderm patterning in the Wnt2-/-;Wnt7b-/- mutants, as noted by 
diffuse expression of Sox9, we examined expression of endothelial and smooth muscle 
markers in Wnt2-/-;Wnt7b-/- mutant lung buds. Combined loss of Wnt2 and Wnt7b leads 
to a significant decrease in smooth muscle gene expression.  Immunostaining for SM22α, 
a smooth muscle marker, shows a dramatic loss, and in some cases absence, of smooth 
muscle development in Wnt2-/-;Wnt7b-/- mutant lungs (Fig. 2.5A,B). Interestingly, while 
loss of Wnt7b leads to decreased expression of endothelial cell markers CD31 and Flk-1, 
QPCR results show that additional loss of Wnt2 did not further decrease expression of 
these genes, while SM22α and SMA show an additional decrease in expression, 
suggesting that smooth muscle differentiation is particularly sensitive to the cooperative 
affects of Wnt2 and Wnt7b signaling (Fig. 2.5C). Together, these data indicate that 
cooperative signaling by Wnt2/Wnt7b is required for proper P-D patterning of early lung 
endoderm progenitors and development of airway smooth muscle from the multipotent 
lung mesenchyme. The affects on Sox9 patterning could be due to the inability of the 
defective mesenchyme to signal back to the developing endoderm to promote P-D 
patterning of Sox9+ progenitors. 
 
Wnt2/Wnt7b cooperative signaling occurs in mesenchymal but not epithelial cell lineages 
Since Wnt2 is expressed in the developing mesenchyme and Wnt7b is expressed 
in the developing epithelium, we wanted to determine whether the cooperation between 
Wnt2 and Wnt7b functions in both cell lineages. Therefore, we expressed Wnt2, Wnt7b 
or both in two additional mesenchymal cells lines Pac1 and 10T1/2 cells, which represent 
rat vascular smooth muscle and mouse embryonic fibroblasts, respectively. We also 
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performed the same experiments in two epithelial cell lines, HEK-293 and MLE15 cells, 
which represent human kidney and mouse lung epithelium, respectively. These studies 
showed that co-expression of Wnt2 and Wnt7b results in cooperative Wnt signaling in 
both Pac1 and NIH-3T3 cells while no cooperative signaling is observed in HEK-293 or 
MLE15 cells (Fig. 2.6A-D). To further assess whether mesenchymal cell lineages are the 
responsive cell type for Wnt2/Wnt7b cooperative signaling and whether this occurs in a 
paracrine manner, we expressed Wnt2 and Wnt7b in RFL6 and HEK-293 cells, 
respectively, while transfecting the STF reporter in only one of the cell types to assess 
cell specific Wnt signaling activity. When the STF reporter is transfected into HEK-293 
cells, Wnt2/Wnt7b cooperative signaling was not observed (Fig. 2.6E).  However, when 
the STF reporter is transfected into RFL6 cells, we observe high levels of Wnt2/Wnt7b 
cooperative signaling (Fig. 2.6E). Taken together, these data indicate that mesenchymal 
cell lineages respond to Wnt2/Wnt7b cooperative signaling in a paracrine manner which 
helps to explain the dramatic loss of airway smooth muscle development in Wnt2-/-
;Wnt7b-/- mutants and also suggests that the defects in patterning of Sox9+ progenitors is 
secondary to defects in the adjacent mesenchyme.   
 
Frizzleds 5 and 8 promote Wnt2/Wnt7b cooperative signaling 
To assess Wnt signaling components that may promote or inhibit Wnt2/Wnt7b 
cooperative signaling, we performed a Q-PCR screen of 84 genes known to be involved 
in the Wnt pathway.  From this screen, Fzd5 was identified as a receptor that is strongly 
induced by Wnt2/Wnt7b cooperative signaling (Fig. 2.7A). Over-expression of Fzd5 in 
RFL6 cells enhances Wnt2/Wnt7b cooperation (Fig. 2.7B). Moreover, siRNA 
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knockdown of Fzd5 inhibits Wnt2/Wnt7b cooperative signaling in RFL6 cells (Fig. 
2.7C). Thus, the finding that Fzd5 can promote Wnt2/Wnt7b cooperative signaling 
suggests that receptor availability may partly explain the ability of Wnt2/Wnt7b to 
display cooperative signaling in mesenchymal but not epithelial cell lineages.  
To test whether expression of Fzd5 could confer Wnt2/Wnt7b cooperation in a 
non-responsive cell type, we transfected Fzd1, Fzd2, Fzd10, and Fzd5 along with Wnt2 
and/or Wnt7b into HEK-293 cells, a cell type normally non-responsive to Wnt2/Wnt7b 
cooperation. Of note, previous studies have shown that Wnt7b displays strong specificity 
for Fzd/LRP receptor combinations and can signal through Fzd1 and Fzd10, but not Fzd4 
or Fzd7 in HEK-293 cells (100). In the current assay, Fzd5 expression was able to confer 
Wnt2/Wnt7b cooperative signaling to HEK-293 cells (Fig. 2.7D).  Interestingly, Fzd5 
increased Wnt2, but not Wnt7b signaling suggesting that Fzd5 promotes the Wnt2/Wnt7b 
cooperative signaling by enhancing Wnt2 and not Wnt7b activity, which is in line with 
previous work showing that Wnt2 synergizes with the Fzd5 receptor in Xenopus axis 
development (101). Although Fzd5 is expressed in the developing lung, the Fzd5 
conditional mutants are viable, suggesting that additional Fzd receptors work redundantly 
with Fzd5 in lung development (101, 102). Fzd8 is highly homologous to Fzd5 and is 
also expressed in the lung (103, 104). Expression of Fzd8 is also sufficient to confer 
Wnt2/Wnt7b cooperative signaling to HEK-293 cells and also increased Wnt2 signaling 
(Fig. 2.7D). These data suggest that specific Fzd receptors including Fzd5 and Fzd8 
transmit Wnt2/Wnt7b cooperative signaling and do so, at least in part, by enhancing 
Wnt2 activity. 
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Wnt2/Wnt7b cooperative signaling does not lead to increased nuclear β-catenin levels 
The dramatic induction in canonical Wnt signaling observed by Wnt2/Wnt7b 
signaling suggests that this cooperation may lead to a concordant increase in nuclear β-
catenin levels. Therefore, we performed Western blots for β-catenin on both cytoplasmic 
and nuclear fractions of RFL6 cells expressing Wnt2, Wnt7b, or Wnt2 and Wnt7b 
(Figure 2.8A). These experiments revealed a lack of increased nuclear or cytoplasmic β-
catenin levels by co-expression of Wnt2 and Wnt7b, although a slight increase was 
observed by expression of Wnt2 alone (Fig. 2.8A). These data suggest that the 
Wnt2/Wnt7b cooperative signaling involves additional pathways and factors beyond 
accumulation of nuclear β-catenin. 
To determine whether β-catenin expression is necessary for Wnt2/Wnt7b 
cooperative signaling, we performed siRNA knockdown of β-catenin in RFL6 cells, 
along with expression of Wnt2 and Wnt7b (Figure 2.8B). Loss of β-catenin resulted in a 
significant decrease in Wnt2/Wnt7b cooperative signaling indicating that while this 
cooperation did not lead to increased levels of β-catenin, steady state expression of β-
catenin is necessary for signaling to occur. Together, these data suggest that β-catenin 
expression is required but additional factors or pathways are necessary to promote 
Wnt2/Wnt7b cooperative signaling.  
 
High-throughput small molecule screen reveals the importance of PDGF signaling on 
Wnt2/Wnt7b cooperative signaling 
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To identify potential pathways that promote Wnt2/Wnt7b signaling independent 
of β-catenin signaling, we performed a high-throughput small molecule screen utilizing 
1280 pharmacologically active compounds (LOPAC-Library of Pharmacologically 
Active Compounds) that selectively inhibit components of most major signaling 
pathways to detect pathways important for Wnt2/Wnt7b cooperation.  We excluded hits 
that promoted cell cycle arrest, cell death, or proliferation based on software 
accompanying the library and focused on multiple hits towards common signaling 
pathways that inhibited signaling by at least 35% (Figure 2.9A). This screen identified 
four compounds that target the epidermal growth factor (EGF)/PDGF signaling 
pathways: 1) Tyrphostin AG1478, a selective inhibitor of EGFR activity (105), 2) U0126, 
a MEK1/2 inhibitor (106), 3) GW2974, a dual EGFR and ErbB-2 receptor tyrosine kinase 
inhibitor (107), and 4) Tyrphostin A9, a selective PDGFR tyrosine kinase receptor 
inhibitor (108).  Interestingly, the EGF and PDGF pathways have been implicated in 
regulating Wnt signaling activity (33, 109). All four of these compounds inhibited 
Wnt2/Wnt7b cooperative signaling in a dose dependent manner (Figure 2.9B-E). 
Based on our findings that expression of β-catenin is necessary for Wnt2/Wnt7b 
cooperative signaling, but steady state levels of β-catenin do not change significantly in 
this cooperative signaling, we assessed whether inhibition of EGF or PDGF signaling 
inhibited Wnt/β-catenin signaling in general, or specifically inhibited the Wnt2/Wnt7b 
cooperative signaling. A pathway inhibitor that affects Wnt2/Wnt7b cooperative 
signaling without affecting activated β-catenin signaling would implicate this pathway in 
the specific regulation of Wnt2/Wnt7b signaling. These studies show that only the PDGF 
signaling inhibitor Tyrphostin A9 inhibits Wnt2/Wnt7b cooperative signaling without 
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effecting activated β-catenin signaling (Fig. 2.10A,B).  To further support the PDGFR 
chemical inhibitor data, we expressed a dominant negative truncated form of PDGFR-α 
(PDGFR-α Truncated) in RFL6 cells, along with Wnt2, Wnt7b, and STF.  We observed a 
similar decrease in the cooperation between Wnt2 and Wnt7b with the expression of a 
truncated form of PDGFR-α as we observed with Tyrphostin A9 (Fig. 2.10C). To test 
whether activation of PDGF signaling could enhance Wnt2/Wnt7b cooperative signaling, 
RFL6 cells expressing Wnt2 and Wnt7b were treated with recombinant PDGF-BB ligand. 
These studies show that PDGF-BB causes a significant increase in Wnt2/Wnt7b 
cooperative signaling (Fig. 2.10D).  
 
PDGF signaling is necessary for smooth muscle development and Wnt signaling in the 
lung 
To determine if this potent role for PDGF signaling in the Wnt2/Wnt7b 
cooperation is necessary for smooth muscle development in the lung, lung explants were 
treated with splice blocking morpholinos against PDGFR-α and PDGFR-β, which 
resulted in significantly decreased expression of these two receptors (Figure 2.11A). 
Knockdown of PDGFR-α and PDGFR-β resulted in a significant decrease in smooth 
muscle gene expression as well as a decreased smooth muscle development surrounding 
the lung airways (Fig. 2.11B,C). Moreover, decreased PDGFR-α/β expression in the lung 
leads to decreased axin2 gene expression, suggesting that PDGFR-α/β are required for 
endogenous levels of Wnt activity in the lung (Fig. 2.11D).  To further assess whether the 
combined activity of the Wnt2 and Wnt7 ligand families could cooperatively increase 
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smooth muscle development in the lung, we treated lung explants with recombinant 
Wnt2, Wnt7a, or Wnt2 plus Wnt7a. Recombinant Wnt7a was used in these studies 
because recombinant Wnt7b is not available and Wnt7a cooperates with Wnt2 in vitro.  
These data show that Wnt2 and Wnt7a can cooperatively increase both smooth muscle 
gene expression and development in the lung (Fig. 2.12A,B). Together, these data reveal 
a novel Wnt signaling mechanism whereby PDGF signaling promotes a specific 
Wnt2/Wnt7b cooperative signaling mechanism required for mesenchymal cell 
differentiation in lung morphogenesis (Fig. 2.13A).  
 
DISCUSSION 
In this study, we show that specific Wnt ligands can cooperatively induce high 
levels of Wnt signaling to regulate P-D patterning and mesenchyme development in the 
lung.  We found that the combinatorial actions of Wnt2 and Wnt7b promote 
mesenchymal cell specific Wnt activity that is mediated, in part, through the PDGF 
pathway.  While this cooperative effect of Wnt2/Wnt7b signaling requires β-catenin 
activity, it does not result in an increase in nuclear steady state expression levels of β-
catenin. The necessity of this Wnt2/Wnt7b cooperation is demonstrated by the dramatic 
lung phenotype in Wnt2-/-;Wnt7b-/- mutant lungs, which display a severe truncation of 
branching morphogenesis along with, disrupted distal endoderm progenitor patterning. 
Our results highlight the importance of reciprocal epithelial/mesenchymal signaling for 
lung development and show the necessity of specific combinations of Wnt ligands to 
promote foregut derived organ development. 
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Epithelial-mesenchymal interactions are a recurrent theme throughout embryonic 
development.  Though the foregut endoderm begins as an undifferentiated sheet of 
epithelium, the ventral aspect of the foregut endoderm will eventually give rise to 
complex, multicellular organs such as the thyroid, lung, liver, and ventral pancreas. The 
specification and the subsequent differentiation of this endoderm into a myriad of organ 
specific epithelial lineages are dependent upon epithelial-mesenchymal interactions.  
Recent work in the pluripotent stem cell reprogramming field has shown the requirement 
of temporally specific expression of Wnt signaling to differentiate foregut endoderm cells 
into lung endoderm (110).  If Wnt signaling is activated prior to the expression of anterior 
foregut endoderm markers, the reprogrammed cells express posterior endoderm markers.  
Following endoderm reprogramming to anterior foregut endoderm, Wnt3a, in 
combination with additional growth factors, is required in a precise time window to allow 
for the ventralization, and not dorsalization, of the anterior foregut endoderm. Then, to 
promote the expression of distal lung endoderm markers, continued Wnt3a expression, in 
addition to retinoic acid and Fgf ligands, is required (110).  The exogenously applied 
growth factors exemplify an in vitro system modeling the in vivo requirement for 
epithelial to mesenchymal signaling for epithelial lung cell differentiation.     
An abundance of literature highlights the in vivo importance of epithelial-
mesenchymal interactions for lung specification and development. During lung endoderm 
specification, Wnt2/Wnt2b ligands function in a paracrine manner to specify Nkx2.1+ 
lung endoderm progenitors within the ventral anterior foregut endoderm.  Conditional 
deletion of β-catenin from the foregut endoderm phenocopies the Wnt2/Wnt2b lung 
agenesis phenotype indicating that Wnt2/2b act in a canonical fashion to specify Nkx2.1+ 
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lung progenitors.  These studies also showed that Wnt2/2b expression is required for 
Wnt7b expression in the anterior foregut endoderm. Based on the present and previous 
studies, we propose a model in which Wnt2 activates the canonical Wnt pathway in the 
anterior foregut endoderm including Wnt7b expression. Expression of Wnt7b, along with 
PDGFR activity, promotes maximal Wnt signaling activity in the lung mesenchyme that 
promotes proper differentiation of specific cell lineages such as smooth muscle. How 
Wnt7b promotes this maximal signaling in cooperation with PDGF signaling is unclear 
but could involve several different mechanisms including post-translational modifications 
of β-catenin that enhance its activity by releasing the repressive activity of a repressor, or 
enhancing the activity of a β-catenin co-activator. 
We have shown that while β-catenin is required for the cooperation between 
Wnt2 and Wnt7b, the accumulation of β-catenin is not solely sufficient.  Our work has 
shown that the combination of Wnt2 and Wnt7b does not result in a concordant increase 
in β-catenin accumulation that could explain the high levels of reporter activity observed. 
Examples of increased β-catenin signaling, with modest to no effects on β-catenin 
accumulation, have been seen in previous studies where modifications to β-catenin or the 
binding of co-activators to promoter regions enhances canonical signaling.  The 
transcriptional co-activator p300 has been shown to affect the activity of β-catenin 
through acetylation.  This acetylation results in an increased β-catenin affinity for Tcf4 
and higher levels of signaling, without affecting nuclear β-catenin accumulation (111). 
Protein kinase A (PKA) has been shown to phosphorylate β-catenin, which results in β-
catenin binding to the transcriptional coactivator CREB- binding protein, leading to 
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increased signaling without affecting β-catenin accumulation (112).  A similar 
mechanism could occur in the cooperation between Wnt2 and Wnt7b, in which PDGF 
signaling results in co-activator activation leading to high levels of canonical signaling, 
without a reciprocal increase in nuclear β-catenin accumulation.  
Our finding that Wnt2 and Wnt7b specifically cooperate during lung development 
to uniquely enhance transcriptional activation may allow for refinements in current 
reprogramming techniques.  We show that simply activating the canonical Wnt pathway 
is not sufficient to replicate the cooperative activity of the Wnt2 and Wnt7b 
ligands.  Although Wnt3a has been used to promote reprogramming of iPS cells into lung 
endoderm, our work suggests that there exist distinct functions for specific Wnt ligands 
that should to be taken into account for promotion of lung progenitor cell fates.  These 
combinatorial actions of specific Wnt ligands may explain how broad domains of 
canonical Wnt activity during embryonic development affect only specific cell lineages 
to allow for organ specification and development. 
 
MATERIALS AND METHODS 
Animals 
Generation and genotyping of Wnt7bLacZ and Wnt2 mouse lines have been previously 
described (4, 23).  Embryos were collected from E10.5-E12.5 as noted. The University of 
Pennsylvania Institutional Animal Care and Use Committee approved all animal 
protocols. 
 
Histology 
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Embryos were collected and fixed in 4% paraformaldehyde (PFA) for 
immunohistochemistry and in situ hybridization.  Following fixation, embryos were 
dehydrated in an increasing gradient of ethanol washes, imbedded in paraffin, and 
sectioned.  Tissue sections were immunostained with the following antibodies: anti-
Nkx2.1 (Santa Cruz), anti-p63 (Santa Cruz), anti-Sox2 (Seven Hills Bioreagents), anti-
Sox9 (Santa Cruz), and anti-SM22alpha (Abcam). In situ hybridization was performed as 
previously described (4, 23). For all histology, at least 3 control embryos and at least 3 
Wnt2-/-;Wnt7b-/- embryos were stained and visualized.  
 
Cell Culture and Transient Transfection Assays 
RFL6, Pac1, and HEK293 were cultured in DMEM supplemented with 10% FBS and 1% 
antibiotic/antimycotic. 10T1/2 cells were cultured in Eagle’s Basal medium 
supplemented with 10% FBS, 2mM L-Glutamine, and 1% antibiotic/antimycotic. MLE15 
cells were cultured in HITES medium supplemented with 10% FBS and 1% 
penicillin/streptomycin as previously described (113).  Cells were transfected with the 
indicated expression plasmids using Fugene 6 (Roche).  Forty-eight hours following 
transfection, luciferase assays were performed using the Dual-Luciferase Reporter Assay 
System (Promega).  For Wnt1 and ABC transfections, Wnt1 and ABC levels were titrated 
for sub-maximal STF activation.  For cell mixture experiments, RFL6 and HEK293 cells 
were transfected with the indicated plasmids for 24 hours after which they were mixed in 
equal numbers. Forty-eight hours following mixture, luciferase assays were performed.  
For siRNA knockdown experiments, 24 hours following transfection with expression 
vectors, cells were transfected with siRNA pools against b-catenin or Fzd5 (Dharmacon) 
 44 
using Lipofectamine 2000 (Invitrogen). Luciferase assays were performed 24 hours 
following transfection of siRNA. For chemical inhibitor assays, 24 hours following 
transfection with expression vectors, chemical inhibitors were added at the indicated 
concentrations for 24 additional hours, followed by luciferase assays.  All of the indicated 
chemical inhibitors were obtained from Sigma and solubilized in DMSO.  
For cell culture assays, a pCMV b-gal plasmid was used as a control plasmid to equalize 
the amount of plasmid being transfected per condition.  50,000 cells were plated in each 
well of a 24-well plate on Day 1. On Day 2, the wells were transfected in triplicate, with 
a half well excess calculated, as shown below: 
  
pCMV β-
gal Wnt2 Wnt7b STF Renilla 
Control 0.4075 µg     0.2083 µg 0.1042 µg 
Wnt2 0.3033 µg 0.1042 µg   0.2083 µg 0.1042 µg 
Wnt7b 0.3658 µg   0.0417 µg 0.2083 µg 0.1042 µg 
Wnt2+Wnt7b 0.2616 µg 0.1042 µg 0.0417 µg 0.2083 µg 0.1042 µg 
 
Fugene 6 was used as the transfection reagent, and was added at a ratio of 3uL per 1ug of 
plasmid.  On Day 4, we used the Dual-Luciferase Assay System to perform luciferase 
assays.  To normalize transfection efficiency, the firefly luciferase values were divided by 
the Renilla luciferase values, and the ratio was used to compare the control, Wnt2, 
Wnt7b, and Wnt2+Wnt7b conditions. 
Rat On-Target Plus SMARTpool siRNAs were purchased from Dharmacon (Ctnnb1 L-
100628-00-0005, Fzd5 L-095098-01-0005, Non-Targeting Pool D-001810-10-05). 
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Quantitative PCR and Western blotting 
Total RNA was isolated from cells and tissues using Trizol reagent, reverse transcribed 
using SuperScript II First-Strand Synthesis Kit (Invitrogen), and used in quantitative real-
time PCR analysis utilizing SYBR green (Applied Biosystems). Lung explant mRNA 
was isolated using the Qiagen RNeasy Mini Kit.  For Western blotting, cells were 
collected 48 hours following transfection, lysed, and nuclear and cytoplasmic fractions 
were generated using a standard protocol. Briefly, 500mL of Buffer A (10mM HEPES, 
1.5mM MgCl2, 10mM KCl, 0.5mM DTT, 0.05% NP40) was added to transfected cells, 
cells were scraped, and lysates were incubated for 10 minutes on ice.  Lysates were 
centrifuged at 40C at 3000rpm for 10 minutes, and the supernatant was collected as the 
cytoplasmic fraction.  The pellet was resuspended in Buffer B (300mM NaCl, 5mM 
HEPES, 1.4mM MgCl2, 0.2mM EDTA, 0.5mM DTT, 26% glycerol, and protease 
inhibitor cocktail), homogenized, and incubated on ice for 30 minutes.  Nuclear lysate 
was centrifuged at 21,130 g’s at 40C for 30 minutes.  The supernatant was collected as the 
nuclear fraction. Protein concentration was quantified using the Bio-Rad Protein Assay 
and 15mg of protein were resolved on SDS-PAGE gels and transferred to PVDF 
membranes.  Antibodies used include in Western blotting include: b-catenin (BD 
Transduction Laboratories), b-tubulin (Abcam), HN-RNPA1 (Santa Cruz Biotech). 
 
LOPAC high-throughput small molecule screen 
RFL6 cells were transfected with CMV-bgal or pcDNA3.1-Wnt2 and Wnt7b expression 
plasmids, along with STF. Twenty-four hours following transfection, cells were replated 
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into 384-well tissue culture plates at 3X104 cells per well and compounds from the 
Library of Pharmacologically Active Compounds (LOPAC) library (Sigma-Aldrich) were 
added at a final concentration of 10mM. Twenty-four hours following plating and 
addition of the LOPAC library, luciferase assays were performed using BriteLite reagent 
(Perkin-Elmer).  The assay was repeated and data was normalized to the median of each 
384 well plate.   
 
Lung Explant Culture 
Lungs were isolated from E11.5 CD1 embryos and cultured in phenol free DMEM/F12 
(Cellgro) on 0.4mm transwells (Falcon) for either 48 or 72 hours at 37 degrees C and 5% 
CO2.  Lungs for Q-PCR were cultured for 48 hours, and lungs for immunohistochemistry 
were cultured for 72 hours. PDGFRa and PDGFRb morpholinos (GeneTools) were added 
into the culture medium at a concentration of 15uM.  The PDGFR-α morpholino 
(ATGTGTGGATACATACCTGTGAGG) targeted the splice donor site of exon 2, and 
the PDGFR-β morpholino (ATCTGTCAAGAGCAGAGCCAAGGAA) targeted the 
splice acceptor site of exon 4.  A standard control morpholino 
(CCTCTTACCTCAGTTACAATTTATA) designed by Gene-Tools was used as the 
control morpholino.  Morpholino knockdown was assessed by QPCR using primers 
(TGAGGGAGAGAAACAAACGGAGGA) and 
(AGCTCCTGAGACCTTCTCCTTCTA) for PDGFR-α and 
(ACCAGCGAGGTTTCACTGGTACTT) and (ATCATTGCCCATCACAATGCACCG) 
for PDGFR-β.  Recombinant Wnt2 (Novus Biologicals) and recombinant Wnt7a (R&D) 
were added to the culture medium at a concentration of 0.25ug/mL.  For QPCR, at least 3 
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lungs were pooled for RNA for each experimental condition, with the number held 
constant between compared conditions, and for histology, at least 3 lungs were visualized 
for each condition. 
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 49 
Figure 2.1 Wnt2/Wnt7b expression patterns in early lung development 
In situ hybridizations show that Wnt2 is expressed in the developing lung mesenchyme 
from E9.5-E11.5 (A, C, E, arrows), while Wnt7b is expressed in the developing lung 
endoderm from E9.5-E11.5 (B, F, arrowheads). (D) The Wnt7bLacZ allele can be used to 
visualize Wnt7b expression in the lung endoderm, which signals to the surrounding Wnt2 
positive mesenchyme (arrows).  The endoderm of the lung is outlined. 
 50 
 
  
 51 
Figure 2.2 Wnt2 and Wnt7b cooperate and show ligand specificity 
Expression of Wnt2 and Wnt7b promote high levels of cooperative signaling activity as 
noted by the activation levels of the STF reporter (A) and by measuring endogenous 
Axin2 expression by Q-PCR (B) as readouts of Wnt signaling.  Wnt2 does not cooperate 
with Wnt1 or Wnt5a to promote STF activity (C). Wnt7b does not cooperate with Wnt1 
or Wnt5a to promote STF activity (J). Wnt2b can cooperate with Wnt7b (E) and Wnt7a 
can cooperate with Wnt2 (F) to drive high levels of Wnt signaling. Wnt2 does not 
cooperate with activated β-catenin to promote STF activity and Wnt7b plus activated β-
catenin results in only an additive increase in STF activity (G). 
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Figure 2.3 Wnt2-/-;Wnt7b-/- double mutant lungs are hypoplastic and have severe 
branching defects 
While Wnt2-/-;Wnt7b-/- mutants at E10.5 and E11.5 do form a separate trachea/lung and 
esophagus (A and B, E and F, red versus black arrows), but the lung fails to undergo 
extensive subsequent branching after the first airway bifurcation (H, black arrow). By 
E12.5, Wnt2-/-;Wnt7b-/- mutant lungs have not progressed while control (Wnt2+/-
:Wnt7b+/-) lungs have branched extensively (I and J). The expression patterns of Nkx2.1 
and p63 at E10.5, which mark the primitive trachea (T) and esophagus (E) respectively, 
are normal in Wnt2-/-;Wnt7b-/- mutants compared to double heterozygous controls (K-
N). E= esophagus, T=trachea. 
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Figure 2.4 Proximal to distal patterning is disrupted in Wnt2-/-;Wnt7b-/- double 
mutant lungs 
The Sox2 expression pattern, which marks the proximal endoderm progenitor population, 
is normal in Wnt2-/-:Wnt7b-/- mutants compared to controls (A-D). However, the Sox9 
expression pattern is more diffuse indicating defective distal progenitor development in 
Wnt2-/-:Wnt7b-/- mutants (E-H). D=distal lung endoderm, P=proximal lung endoderm, 
T=trachea.  The lung endoderm is outlined. 
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Figure 2.5 Smooth muscle formation is disrupted in Wnt2-/-;Wnt7b-/- double 
mutant lungs 
SM22α expression reveals a significant loss in smooth muscle development in Wnt2-/-
;Wnt7b-/- mutants (A,B, arrows). Q-PCR analysis shows that smooth muscle markers 
SM22α and smooth muscle α-actin (SMA) are decreased in a cooperative manner by loss 
of both Wnt2 and Wnt7b expression while endothelial markers are decreased in Wnt7b-/- 
mutants but loss of Wnt2 does not lead to a further decrease (C).  
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Figure 2.6 Cooperation between Wnt2/Wnt7b is specific to mesenchymal cells 
Wnt2-Wnt7b cooperative signaling occurs in Pac1 and 10T1/2 cells while no cooperation 
is observed in HEK293 and MLE15 cells (A-D).  Wnt2-Wnt7b cooperative signaling 
occurs robustly in a paracrine fashion in mesenchymal cells (RFL6) but less so in 
epithelial cells (HEK293) in a cell mixture assay (E). 
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Figure 2.7 Cell type specificity may be a result of Fzd5 and Fzd8 availability 
Analysis of a Q-PCR Superarray assay shows that Fzd5 is induced by Wnt2/Wnt7b 
cooperative signaling (A). Over-expression of Fzd5 in RFL6 cells can strongly enhance 
Wnt2/Wnt7b cooperative signaling (B) while siRNA knockdown of Fzd5 expression 
inhibits this cooperation (C). Amongst Fzd’s tested including Fzd1, Fzd4, and Fzd10 only 
Fzd5 and the highly related Fzd8, can confer Wnt2/Wnt7b cooperative signaling to 
normally non-responsive HEK293 cells (D). 
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Figure 2.8 β-catenin is necessary but not solely responsible for the cooperation 
between Wnt2/Wnt7b 
RFL6 cells transfected with Wnt2, Wnt7b, or Wnt2+Wnt7b expression plasmids were 
fractionated as described in the Materials and Methods section and Western blots were 
performed on cytoplasmic and nuclear protein fractions.  While a slight increase in β-
catenin levels were observed for Wnt2 expressing cells, no further increase was observed 
in Wnt2+Wnt7b expressing cells (A).  The nuclear and cytoplasmic fractions were pure 
as noted by separate expression of β-tubulin and HNRNPA-1, respectively.  siRNA 
knockdown of β-catenin in RFL6 cells inhibits the Wnt2-Wnt7b cooperation (B). 
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Figure 2.9 PDGF and EGF pathway inhibitors decrease the cooperation between 
Wnt2 and Wnt7b 
The LOPAC library was screened for compounds that inhibit the Wnt2-Wnt7b 
cooperative signaling.  From this screen, 37 compounds were identified that inhibited the 
Wnt2/Wnt7b signal by at least 35% (A). Of these, four compounds, AG1478, U0126, 
GW2974, and Tyrphostin A9 targeted the EGFR or PDGFR pathways (denoted by *). All 
four compounds inhibited Wnt2-Wnt7b cooperative signaling in a dose dependent 
manner (B-E). Of note, cell survival was not affected in all doses less than 10mM (data 
not shown). 
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Figure 2.10 The PDGF pathway specifically affects the cooperation between Wnt2 
and Wnt7b 
The effects of AG1478, U0126, GW2974, and Tyrphostin A9 on Wnt2/Wnt7b signaling 
and activated β-catenin signaling were compared using the 1mM dose for each 
compound. While AG1478, U0126, and GW2974 all inhibited β-catenin signaling (A), 
only Tyrphostin A9 affected Wnt2/Wnt7b signaling specifically, without affecting β-
catenin signaling (B).  A dominant negative truncated PDGFR-a decreases the 
cooperation between Wnt2/Wnt7b, adding support to the Tyrphostin A9 chemical 
inhibitor data (C). The addition of PDGF-BB ligand to Wnt2+Wnt7b transfected RFL6 
cells results in increased STF activation at a concentration of 25ng/mL (D). 
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Figure 2.11 Knockdown of PDGFRs results in decreased smooth muscle formation 
and Wnt signaling 
The PDGFR-α and PDGFR-β morpholinos knock down the expression of PDGFR-α by 
approximately 80% and PDGFR-β by approximately 90% in cultured lung explants (A).  
The knockdown of PDGFR-α and PDGFR-β results in decreased smooth muscle markers 
SMA and SM22α by Q-PCR (B) and expression of SM22α is decreased by 
immunohistochemistry, as denoted by arrows (C).  The knockdown of PDGFR-α and 
PDGFR-β also decreases the Wnt downstream target, Axin2, demonstrating decreased 
Wnt signaling with the loss of PDGF in the lung explants. 
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Figure 2.12 Overexpression of rWnt2 and rWnt7a results in increased smooth 
muscle formation 
Addition of rWnt2 and rWnt7a to lung explant cultures results in increased SM22α 
expression, compared to lung explants cultured without recombinant Wnt, arrows point to 
SM22α expression, dashed line denotes lung endoderm outline (A).  QPCR for SM22α 
and SMA on lung explants treated with rWnt2, rWnt7a, or rWnt2+rWnt7a show 
increased smooth gene transcription only with the combination of rWnt2 and rWnt7a (B). 
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Figure 2.13 Model of cooperation between Wnt2/Wnt7b/PDGF 
Epithelial Wnt7b signals in a paracrine manner to Wnt2 expressing mesenchymal cells.  
The combined action of Wnt2 and Wnt7b, in combination with PDGF signaling, results 
in increased canonical Wnt signaling, which allows for proper smooth muscle 
development and proximal-distal patterning of the lung epithelium. 
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CHAPTER 3: High throughput genomic screen identifies multiple factors that 
promote cooperative Wnt signaling 
A portion of the data presented in this chapter is included in a forthcoming manuscript. 
Summary 
In Chapter 2, I demonstrated that Wnt2 and Wnt7b can promote high levels of 
cooperative signaling in a cell type specific manner. To explore the underlying 
mechanism of this cooperative Wnt signaling, we performed a high-throughput screen of 
more than 14,000 cDNAs to identify genes that promote Wnt signaling in the context of a 
single Wnt ligand, Wnt2. This screen identified several homeobox containing genes 
including Msx2, Nkx5.2, and Esx1, in addition to other factors known to promote Wnt 
signaling, including Pias4. Generation of dominant-active or dominant-negative forms of 
the Msx homeodomain indicate that the mechanism by which this  homeobox factor 
cooperatively promotes Wnt signaling is through its ability to repress gene transcription. 
These data identify a broad homeobox code, which acts to increase Wnt signaling 
through transcriptional repression. 
 
Introduction 
As shown in Chapter 2, cooperative signaling by Wnt2 and Wnt7b is necessary 
and sufficient to promote smooth muscle and distal endoderm progenitor cell 
development in the lung.  Moreover, this cooperative activation of Wnt signaling, while 
requiring β-catenin expression, is not the result of increased β-catenin stabilization.  
Precedent for increased Wnt signaling without a concomitant increase in β-catenin 
protein levels has been demonstrated by the activity of β-catenin co-activators, including 
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p300 and pontin52, both of which cause a significant increase in Wnt reporter activation 
without increasing β-catenin stabilization (114, 115).   
Homeotic (Hox) transcription factors are a large group of transcriptional 
regulators that are critical for embryonic development.  Hox genes were first discovered 
in Drosophila as random gene duplication and deletion events resulting in structure 
duplication i.e. a fly with two pairs of wings.  The genes causing these segment 
duplication and deletion mutations were found to contain highly homologous DNA 
binding domains of 180 base pairs with extremely high evolutionary conservation (116, 
117).  Interestingly, Hox genes are distributed along chromosomes in the same anterior to 
posterior position that they are expressed in the body.   
In the mouse, there are 39 Hox genes located on four chromosomes.  They are 
thought to have arisen from gene and chromosomal duplication events of the original 
eight Drosophila Hox genes, which are located on a single chromosome (118).  
Paralogous Hox genes have the same number designation, and are differentiated by letter 
e.g. hoxa-3, hoxb-3, hoxc-3, and hoxd-3.  Paralogues are homologous enough that they 
can be substituted for each other (118).  Hox genes in the same family are all related by a 
highly homologous homeobox DNA binding domain and can function as transcriptional 
activators or repressors.         
Several homeobox genes have been implicated in enhancing Wnt signaling.  For 
example, Pitx2, a paired-homeodomain containing gene (Prd), can directly bind to β-
catenin and synergistically activate the promoter of Lef-1 (119). The homeobox factor 
Hhex binds to a Wnt signaling repressor, Sox13, displacing it from Tcf3/4 to relieve 
transcriptional repression and allow for Wnt mediated transcriptional activation (120).  
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Such studies indicate the importance of homeobox factor interactions in promoting Wnt 
signaling activity.  
In this Chapter, I perform a gain of function high throughput cDNA 
overexpression screen to further interrogate the mechanism of the cooperation between 
Wnt2 and Wnt7b.  I identify multiple homeobox factors that promote high levels of 
signaling in the presence of Wnt2. These results indicate that a homeobox “code” may be 
important for Wnt signaling activity in lung development.  The work in this chapter may 
have broader implications for development along the entire embryonic axis, where areas 
of Hox gene and Wnt expression overlap define specific transcriptional responses. 
 
RESULTS 
Optimization of Wnt2/Wnt7b transfection for high throughput genomic screen 
The work described in Chapter 2 demonstrates the importance of the cooperation 
between Wnt2 and Wnt7b in the development of the early mouse lung (121).  To 
determine factors that could act upstream or downstream of Wnt2, we performed a high 
throughput screen (HTS), in collaboration with John Hogenesch’s lab at the University of 
Pennsylvania, utilizing the Mammalian Genome Collection (Open Biosystems), which 
includes 9,017 mouse and 5,445 human full length cDNAs driven by the CMV promoter 
arrayed in 46 x 384-well plates.  We performed the screen in RFL6 cells, the same cell 
line that most of the work in Chapter 2 was performed in (121). To carry out this screen, 
we first scaled down our STF Wnt cooperation assay to a 384-well plate format, from a 
6-well plate format.  To do this, we scaled down into a 96-well plate format, and then 
scaled down to a 384-well plate format, optimizing plasmid and transfection reagent 
 77 
ratios as well as cell number (Fig. 3.1A). Additional steps were taken to ensure that the 
signal to noise ratio between control transfected cells and cells transfected with 
Wnt2+Wnt7b plasmids was significant enough that the screen produced consistent and 
reproducible results. 
To perform the screen, a transfection mix containing control expression plasmids 
as well as the STF reporter, along with the transfection reagent Fugene HD, was added to 
384-well plates containing the Mammalian Genome Collection in expression vectors 
(Fig. 3.1B). RFL6 cells were then added to the wells and after a 48-hour incubation 
period, the STF activity was quantified utilizing the BriteLite assay and the Perkin Elmer 
Envision luminometer.  The screen was performed twice and the STF measurements were 
normalized and averaged. 
 
Validation of HTS results 
A cut-off point of 35-fold or higher than the median value of each 384-well plate 
was chosen to identify cDNAs from the screen for further investigation.  This resulted in 
23 unique genes to validate (Fig. 3.1B).  From the 23 genes, we tested whether they could 
activate the STF reporter by themselves or if they would activate the SuperFOPFLASH 
(SFF) reporter, which has mutated LEF/TCF sites and thus should not be activated by 
Wnt signaling activity.  Of the 23 genes, five genes specifically activated the STF 
reporter in combination with Wnt2 (Fig. 3.2A). Of these five, three were homeobox 
containing genes (Esx1, Msx2, and Nkx5.2) and one was the sumoylation factor Pias4, 
which is known to regulate and alter Wnt/β-catenin signaling (122-126). All of these 
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factors cooperatively enhanced Wnt signaling when co-expressed with either Wnt2 or 
Wnt7b (Fig. 3.2B-F). 
 
Msx1 and Msx2 function as repressors of repressors in the cooperation between Wnt2 
and Wnt7b 
Of the three homeobox genes, we chose to focus on Msx2, and its highly related 
family member Msx1, since previous reports have demonstrated that these factors 
regulate Wnt signaling, particularly in mesenchymal cells (127-131). To determine 
whether the Msx1/2 genes enhance the activity of other Wnt ligands, we expressed 
Msx1/2 along with either Wnt1 or Wnt5a in RFL6 cells.  When co-expressed with Wnt2 
and Wnt7b, the fold activation Msx1/2 were able to confer over the Wnt alone was 18 
and 20 fold, respectively (Fig. 3.3A and B).  However, with Wnt1 and Wnt5a, Msx only 
enhanced the signal by 5-fold for Wnt1, and had no positive effect on Wnt5a signaling 
(Fig. 3.3C and D).  These data suggest that Msx1/2 enhance canonical Wnt signaling and 
that their effects are Wnt ligand specific.  
To determine whether Wnt2 or Wnt7b activity can affect the transcription of 
Msx1 or Msx2, we performed qualitative Q-PCR on RFL6 cells expressing Wnt2 and/or 
Wnt7b. These studies show that increased Wnt2 and Wnt7b expression induce both Msx1 
and Msx2 (Fig. 3.4A). Next, we wanted to determine how Msx1/2 affect the cooperation 
between Wnt2 and Wnt7b.  To determine the activity of Msx1/2 in the context of Wnt2 
and Wnt7b, we produced fusion constructs containing the Msx1 homeodomain (MsxHB) 
to construct MsxHB-Engrailed and MsxHB-VP16 expression plasmids to repress and 
activate Msx target genes, respectively (Fig. 3.4B). The MsxHB-VP16 construct, which 
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we initially hypothesized would increase the cooperation between Wnt2 and Wnt7b, 
decreased the Wnt2/Wnt7b cooperative signaling. In contrast, the MsxHB-Engrailed 
construct increased Wnt2/Wnt7b cooperative Wnt signaling (Fig. 3.4C,D).  Thus, our 
findings suggests that Msx1/2, and possibly other homeobox factors, promote cooperative 
Wnt2/Wnt7b signaling by repressing gene expression.  
 
Microarray to determine repressors of Wnt signaling that are down regulated in 
Wnt2/Wnt7b cooperation 
The results of the VP16 and engrailed fusion constructs led to the hypothesis that 
the role of Msx, or a gene containing the conserved homeodomain, is acting as a 
repressor of a Wnt repressor.  A list of known Wnt repressors was compiled and QPCR 
was performed to determine if any known Wnt repressors show decreased transcriptional 
activity when Wnt2 and Wnt7b are transiently overexpressed.  From our candidate list, 
none showed a decrease in transcription levels (Fig. 3.5A-C).  Therefore, to expand our 
inquiry of possible candidate repressors, we performed a microarray comparing the 
transcriptional profiles of control transfected RFL6 cells, Wnt2 transfected cells, Wnt7b 
transfected cells, and Wnt2+Wnt7b transfected cells.   
From the microarray, we found 247 genes are down regulated two-fold or greater 
(p-value </= 0.05) when comparing the control condition to the Wnt2+Wnt7b condition.  
Three of the genes, RRM2, Racgap1, and Dbf4, stood out as being previously implicated 
to be repressors of Wnt signaling (132-134).  All three genes showed a decrease in 
transcript levels with the addition of Wnt2+Wnt7b, and also with the addition of Msx1 
(Fig. 3.6A).  When the three genes were expressed in the cooperation assay, however, 
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they did not result in a decrease in STF reporter levels, which is what we hypothesized 
would occur if either of these repressors was acting as the repressor of Wnt signaling that 
the Msx genes were affecting (Fig. 3.6B-D). 
 
Does sumoylation affect the activity of Msx1? 
One of the genes identified to cooperatively activate the STF reporter with Wnt2 
was PIAS4, which can function as an E3-SUMO ligase and sumoylate target proteins on 
lysines located in conserved sequence motifs.  PIAS mediated sumoylation is thought to 
enhance the stability of proteins or regulate protein-protein interactions (135).  We found 
that Msx1 has two lysines located in predicted sumoylation motifs, designated 
by ψKxD/E, where ψ is a hydrophobic residue, x is any amino acid, and K is the 
sumoylated lysine (Fig. 3.7A).  By using site directed mutagenesis, we changed lysine 15 
(K15) and lysine 122 (K133) to arginines singly, and in combination.  We found that 
when Msx1 has a K15R or K133R mutation, there is a decrease in the cooperation 
between Wnt2 and Wnt7b.  However, when both K15R and K133R are mutated the 
cooperation between Wnt2 and Wnt7b is restored (Fig. 3.7B).  These data implicate a 
possible role for sumoylation of Msx1 in the cooperation between Wnt2 and Wnt7b, but 
the results of the dual point mutations complicate any interpretation made from the single 
point mutations. 
 
Can the cooperation between Wnt2 and Wnt7b occur in vitro or in vivo without Msx1 or 
Msx2? 
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We next wanted to determine the necessity of Msx1 and Msx2 in the cooperation 
between Wnt2 and Wnt7b.   Commercially available siRNA against Msx1 was not able to 
decrease Msx1 transcript expression below approximately 60% of normal expression 
levels, and at this level of knockdown, there were no significant effects on the 
cooperation between Wnt2 and Wnt7b (Fig. 3.8A,B).  Therefore, we harvested mouse 
embryonic fibroblasts (MEFs) from Msx1fl/fl;Msx2fl/fl embryos and treated the MEFs with 
an adeno-cre virus to cause the recombination of the floxed alleles and produce MEFs 
deficient in functional Msx1 or Msx2.  The recombination was highly efficient, resulting 
in a greater than 80% decrease in Msx1 and Msx2 expression (Fig. 3.8C).  However, the 
cooperation between Wnt2 and Wnt7b still occurred in the Msx1/Msx2 conditional 
mutant MEFs, which can mean 1) there is a redundant gene, such as Msx3, acting in 
place of Msx1 and Msx2, 2) only very low expression levels of Msx1 and Msx2 are 
required for the cooperation, or 3) Msx1 and Msx2 are not necessary for the in vitro 
cooperation between Wnt2 and Wnt7b (Fig. 3.8D). 
We wanted to determine whether or not the in vivo loss of Msx1 and Msx2 would 
result in a lung phenotype similar to the Wnt2/Wnt7b double null lungs.  Because there 
were no available lung mesenchymal Cre lines available at the time this experiment was 
performed, we bred the Msx1fl/fl;Msx2fl/fl females to CMV-cre males to produce Msx1+/-
;Msx2+/-;CMV-cre+ females.  The CMV-cre transgene is X-linked, and therefore, no 
males produced from these breedings will have either Msx gene recombined. We bred 
Msx1+/-;Msx2+/- males and females to produce Msx1-/-;Msx2-/- double null embryos and 
collected at E14.5 (136).  We found that the Msx1-/-;Msx2-/- double null lungs did not 
display a phenotype similar to the Wnt2-/-;Wnt7b-/- double null lungs.   
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DISCUSSION 
Wnt signaling is a critical regulator of early development, as well as stem cell 
differentiation and self-renewal. How the Wnt signaling activity is regulated by 
interactions with transcriptional modulators is still poorly understood. By performing a 
HTS screen with the majority of the coding genes in the mammalian genome, we have 
shown that several homeobox factors cooperate with Wnt2 and Wnt7b to promote high 
levels of Wnt signaling activity in mesenchymal cells. These homeobox factors 
encompass several subfamilies including the Msh, Prd-like, and Nkx subfamilies. Our 
data also suggest that this cooperative increase in Wnt signaling activity is driven by the 
ability of homeobox factors to repress gene transcription, possibly through repression of 
inhibitors of Wnt signaling activity.  However, when we tested the necessity of Msx1 and 
Msx2 for the cooperation between Wnt2 and Wnt7b, we found that while sufficient to 
confer cooperation, they are not necessary.  One possible explanation for this is that the 
Msx gene was found through the use of a gain of function screen, and therefore 
overexpression resulted in an off target, non-endogenous effect.  Gain of function screens 
are useful for finding genes that are sufficient to cause a specific outcome, whereas loss 
of function screens are useful for finding genes that are necessary for a specific outcome.  
Our rationale for performing a gain of function screen was that we wanted to spread the 
widest net to find genes capable of cooperating with Wnt2.  We believe that while we did 
not find the specific gene responsible for the cooperation between Wnt2 and Wnt7b, we 
did discover a broader cooperation between homeobox factors and Wnt signaling. 
Homeobox factors may both promote and fine tune Wnt signaling in specific 
developmental contexts through inhibition of negative inputs of the Wnt pathway. 
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Wnt signaling has been described as a network rather than a single linear pathway 
(137). Our data showing a broad role for homeobox factors in promoting Wnt signaling 
correlates with such a network assessment for Wnt signaling. Several previous reports 
have demonstrated roles for homeobox factors in the Wnt pathway.  Prop1, which 
contains a Prd-like homeodomain, works in conjunction with Wnt signaling by 
interacting with β-catenin to both activate and repress transcription in a tissue specific 
manner to allow for proper cell differentiation in the pituitary gland (138).  Alx4, another 
Prd-domain containing gene, binds to and physically interacts with Lef-1 in vitro, and has 
been shown to genetically interact with Lef-1 in heart, head, and dorsal vessel 
development in vivo (139, 140).   Despite these examples, how homeobox factors 
regulate Wnt signaling output is still unclear. Our studies suggest that transcriptional 
repression may underlie at least part of the mechanism. Such repression could be through 
a simple inhibition of repressors of Wnt signaling allowing for maximal signaling output 
in certain contexts. Alternatively, homeobox factors may inhibit portions of the Wnt 
pathway that provide important negative feedback on signaling. Future studies will be 
needed to assess how homeodomain containing genes promote Wnt signaling through 
transcriptional repression. 
The HTS screen performed in these studies was done in the context of a specific 
ligand, Wnt2. However, most of the positive hits we obtained also showed significant 
cooperative increases with the Wnt7b ligand but not other ligands including Wnt1 or 
Wnt5a. These results further indicate that the large number of Wnt ligands evolved to 
perform specific functions in specific contexts. This is an important concept given the 
wide use of some recombinant Wnt proteins i.e. Wnt3a to demonstrate active Wnt 
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signaling in multiple different contexts (141-144). Thus, our data suggest that the use of a 
Wnt ligand to study a given biological system in vitro should match with the expression 
pattern of the ligands used in vivo where possible.  
 
MATERIALS AND METHODS 
High throughput genomic screen of the Mammalian Gene Collection 
50ng of each cDNA from the Open Biosystems Mammalian Gene Collection was arrayed 
on 46 x 384-well plates.  The final plasmid amount in each well was 155ng (50ng MGC 
cDNA + 40ng Wnt2 expression plasmid + 75ng SuperTopFlash).  FugeneHD (Roche) 
was dispensed at a DNA:Fugene HD ratio of 1µg:3.5µL.  10,000 RFL6 cells were 
dispensed to each well.  The transfected cells were grown in DMEM (Gibco), 10%FBS 
(Gibco), and 1%Antibiotic/Antimycotic (Gibco).  Transfection master mixes containing 
plasmid/DMEM/FugeneHD were dispensed to each well using the Matrix Wellmate.  
20µl of RFL6 cells at 5x105 cells/mL were then dispensed to each well using the Matrix 
Wellmate.  For transfection controls, we utilized both a Wnt7b plasmid and a 
constitutively active b-catenin mutant plasmid.  Plates were incubated at 37oC and 5% 
CO2 for 48 hours.  35µl of BriteLite (PerkinElmer) was dispensed to each well using a 
multi-channel pipette and allowed to incubate for 5 minutes.  Luciferase values were then 
recorded using the PerkinElmer Envision plate reader.  The screen was repeated, and the 
luciferase values for each well averaged.  The median value of each plate was used to 
normalize the values between the 46 plates. 
 
VP16 and engrailed fusions with the Msx homeodomain 
 85 
The VP16 activation domain (amino acids 411-456) was cloned into pcDNA3.1 using 
NheI and KpnI.  The Xenopus engrailed repression domain (amino acids 1-297) was 
cloned into pcDNA3.1 using NheI and KpnI.  MsxHB (amino acids 157-233 of Msx1) 
was cloned into pcDNA3.1 and downstream of the activation and repression domains of 
the VP16 and Engrailed pcDNA3.1 constructs using KpnI and XhoI. 
 
Cell Transfections 
RFL6 cells were plated into 24-well plates at a concentration of 1x105 cells/mL.  One day 
later, cells were transfected using Fugene 6 at a ratio of 3µL Fugene 6:1µg plasmid.  A 
pCMV-βGal plasmid was used as a control plasmid and to equalize total plasmid 
amounts per transfection.  48 hours following transfection, we performed a Dual-
Luciferase Assay (Promega) to determine activation of the STF reporter and Renilla 
transfection efficiency. 
 
QPCR 
Cells were lysed and RNA collected following the Trizol Reagent (Invitrogen) protocol.  
Following DNase treatment (Roche), cDNA was synthesized using the First-Strand 
cDNA synthesis kit (Invitrogen).  QPCR was then performed using the below primers 
and SYBR green (Applied Biosystems). 
Msx1: Forward 5’ TCCTCCTGGCCATCGCATCTTAAA,  Reverse 5’ 
ATATTGGGAAGAGGTGGACAGGCA 
Msx2: Forward 5’ ATTGAAGCCATGTGTTGGGCTTGG,  Reverse 5’ 
ATATTGGGAAGAGGTGGACAGGCA 
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Microarray 
3x10cm plates of RFL6 cells were transfected with each of the following: control 
expression plasmid, the Wnt2 expression plasmid, the Wnt7b expression plasmid, or the 
combination of the Wnt2 and Wnt7b expression plasmids.  48 hours post-transfection, the 
cells were PBS washed, and RNA was isolated using Trizol Reagent.   Following 
isolation, RNA was DNase treated following the Roche DNase I protocol.  Ammonium 
acetate and 2.5 volumes of 100% ethanol were used to precipitate the RNA from the 
DNase reaction.  The RNA was then submitted to the University of Pennsylvania 
Microarray Core and the samples were processed and run on the Affymetrix Rat Gene 
1.0st Array. 
 
Site directed mutagenesis of Msx1 expression plasmid 
We used SUMOsp2.0 to analyze the Msx1 amino acid sequence to determine if there 
were putative sumoylation sites that Pias4 could target.  Two sites were found at K15 and 
K133.  To mutate K to R, primers were made to anneal to the sequence of Msx1 and 
change the sequence to code for an R, instead of a K.  A PCR reaction was set up with 
5ul 10X Takara PCR Buffer, 4µL dNTPs, 1.25µL 100µM primer, 1µL 5-50ng template, 
1µL pfu Turbo Taq, and 33.75µL water.  The PCR machine was set so that for every 1kb, 
there would be 2 minutes extension time.  The PCR program was: step 1 - 95°C 1 minute, 
step 2 – 95° 1 minute, step 3 – 60°C 1 minute, step 4 – 65°-68° C 11 minutes, step 5 – 
68° C 7 minutes, repeat steps 2 – 4 x 18 before progressing to step 5.  Then add 1µL 
DpnI restriction enzyme (10units/µL) directly to PCR product, and incubate for 1 hour.  
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Precipitate DNA with 100% ethanol and resuspend in water.  Transform cells, and 
sequence plasmids for point mutants. 
 
MEF preparation 
Dissect embryos at E13.5 and remove head, limbs, and all organs.  Using a razor blade, 
finely chop the body wall.  Add trypsin and incubate at 37°C until cells disperse.  To help 
cells disperse, pipette trypsin/cell mix vigorously.  When cells are dispersed, add media 
with FBS to inhibit trypsin.  Strain media with cells to ensure single cell suspension (100 
micron pore size), and centrifuge.  Remove media and bring up cells in fresh media. 
  
Transducing and transfecting MEFs 
Day 1: Plate Msx1fl/fl;Msx2fl/fl MEFs at a density of 1x106 cells/mL on a 10cm plate. Day 
2: Transduce with 1000 MOI of either Adeno-Cre virus (H5:040.CMV.PI.CRE, 
4.74x1011 infectious units/mL) or Adeno-LacZ control virus.  Day 3: Change media on 
cells to remove virus. Days 4 and 5: Passage MEFs when needed.  Day 6: Plate 
transduced MEFs into 12-well plates.  Day 7: Transfect MEFs with control, Wnt2, 
Wnt7b, STF, and Renilla plasmids using 6.5µL Invitrogen’s Lipofectamine LTX + 1µL 
Invitrogen’s PLUS Reagent per 1µg plasmid.  Day 9: Perform Promega’s Dual-
Luciferase Assay to determine STF activation values. 
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Figure 3.1 Optimization of high throughput screen 
(A) The standard 6-well assay was first optimized for 96-well format and then for the 
high throughput 384-well format. (B) Diagram of how the 384-well HTS screen was 
performed. Our cutoff was at 35-fold higher than the median of each plate. Each 384-well 
plate contained internal positive and negative controls. Red-dashed line signifies cut-off 
point. 
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Figure 3.2 Results of HTS highlight homeodomain genes’ and a sumoylation gene’s 
capacity to increase Wnt signaling 
(A) The 23 hits that were obtained in the HTS screen were repeated in a 96-well format. 
Two of the hits, Wnt3 and HSPA12B, activated the STF reporter in the absence of Wnt2 
and did not cooperatively promote signaling in the presence of Wnt2.  The five genes 
specifically acting with Wnt2 are denoted by (*). Wnt2 plus Wnt7b cooperatively 
activates STF (B). Expression of Esx1 (C), Msx2 (D), Nkx5.2 (E), and Pias4 (F) further 
promotes this cooperative signaling in the presence of Wnt2 or Wnt7b. 
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Figure 3.3 Msx1 and Msx2 specifically enhance Wnt2 and Wnt7b signaling 
Wnt cooperative signaling assays were performed in RFL6 cells in the presence or 
absence of Wnt1 (A), Wnt7b (B), Wnt5 (C), or Wnt2 (D).  Msx1 and Msx2 cooperate 
more robustly with Wnt2 and Wnt7b than Wnt5 or Wnt1. 
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Figure 3.4 Msx HB acts as a repressor of a repressor 
Wnt2 and Wnt7b increase Msx1/2 gene expression in RFL6 cells (A). Diagram of Msx1 
HB fusion proteins made with the VP16 activation domain and the engrailed repression 
domain (B). Expression of the MsxHB-VP16 fusion represses Wnt2-Wnt7b cooperative 
signaling (C), while expression of the MsxHB-engrailed fusion enhances Wnt2-Wnt7b 
cooperative signaling (D). 
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Figure 3.5 Msx expression in combination with Wnt signaling does not affect ten 
repressors of Wnt signaling 
The transcriptional changes of ten genes implicated in the negative regulation of Wnt 
signaling were determined in the context of Wnt2, Wnt7b, and Wnt2+Wnt7b transfected 
RFL6 cells (A).  The changes in expression seen in (A) were compared to the 
transcriptional changes observed when RFL6 were also transfected with Msx1 (B) or 
Msx2 (B).  None of the tested genes show a significant decrease in transcriptional 
activation following addition of Msx with either Wnt2 or Wnt7b. 
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Figure 3.5 Dbf4, RacGAP1, and RRM2 do not repress the cooperation between 
Wnt2/Wnt7b 
Results from a microarray performed on RFL6 cells transfected with Wnt2 and Wnt7b 
revealed a down regulation of three genes that have been shown to negatively regulate 
Wnt signaling - Dbf4, RacGAP1, and RRM2 (A).  The down regulation of the three 
genes is maintained with the additional transfection of Msx1 into RFL6 cells (A).  
However, there is no change in the activation of STF in either the Wnt2, Wnt7b, or 
Wnt2+Wnt7b conditions with the addition of Dbf4, RacGAP1, or RRM2 (B-D). 
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Figure 3.7 Single point mutations of Msx1 affect Wnt cooperation, while dual point 
mutations reverse the effect 
(A) The amino acid sequence for Msx1 contains two predicted sumoylation sites at K15 
and K133 (highlighted in red).  The grey box denotes the homeodomain region of Msx1.  
(B) Mutation of either sumoylation site in Msx1 results in decreased STF activation with 
Wnt2 and Wnt7b.  However, mutation of both sumoylation sites rescues the decreased 
cooperative activity of Msx1 with Wnt2 and Wnt7b. 
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Figure 3.8 Msx1/2 are not required for the cooperation between Wnt2 and Wnt7b 
(A) siRNA against Msx1 in RFL6 cells results in an approximately 60% decrease in 
Msx1 transcripts, but this decreased expression does not affect the cooperation between 
Wnt2 and Wnt7b (B).  Msx1fl/fl;Msx2fl/fl MEFs transduced with either one dose of 1000 
MOI of Adeno-Cre or two sequential doses of Adeno-Cre at 1000 MOI and then 500 
MOI 48-hours later, results in a robust deletion of Msx1 and Msx2 expression of 
approximately 80% (C).  MEFs transduced with either a control Adeno-LacZ virus or the 
Adeno-Cre virus, which deletes Msx1 and Msx2, show very similar STF activity levels 
with the transfection of Wnt2, Wnt7, or Wnt2+Wnt7b.   
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CHAPTER 4: Conclusions and Future Directions 
Summary 
 Lung development relies upon the precise temporal and spatial interactions of 
multiple signaling pathways.  Both gain and loss of function studies have highlighted the 
importance of Wnt signaling in every aspect of lung development - from specification, to 
branching, to cell differentiation.  However, these studies have focused on single, or 
combinations of redundant, Wnt ligands, or global loss or gain of β-catenin.  The studies 
in this dissertation were focused instead on a cooperative role for Wnt ligands during 
lung development.  The goals of this dissertation were to determine 1) if the 
complementarily expressed Wnt2 and Wnt7b cooperate, 2) what role their cooperation 
has in lung development, and 3) through what mechanism the cooperation occurs. 
 In Chapter 2, I demonstrated that Wnt2 and Wnt7b cooperate both in vitro and in 
vivo to promote high levels of Wnt signaling.  This cooperative activation to spatially and 
temporally fine-tune high levels of canonical Wnt signaling is novel.  Previous studies 
have shown the negative regulation non-canonical Wnt signaling can have on canonical 
Wnt signaling, but positive effects on canonical signaling, to the levels I identified, have 
not been reported.  My studies also show that the PDGF pathway can interact with Wnt2 
and Wnt7b to potentiate β-catenin signaling without increased β-catenin accumulation.  
The precise mechanisms of this interaction are unclear, however there are several post-
translational modifications that may be involved, which I will discuss in my future 
directions.    
 In Chapter 3, I extend my understanding of the cooperation between Wnt2 and 
Wnt7b by performing a high throughput genomic screen to find genes that may function 
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downstream of Wnt2 and Wnt7b.  From this screen, three homeodomain containing genes 
were found to cooperate very strongly with both Wnt2 and Wnt7b.  Of note, a BLAST 
search of one of these homeodomain genes results in the alignment of the homeodomain 
region of the other two genes, suggesting that these genes may have similar 
transcriptional targets.  While we were not able to determine the precise gene involved in 
the cooperation between Wnt2 and Wnt7b, we have found that homeodomain containing 
genes can cooperate with Wnt ligands to activate high levels of canonical Wnt signaling.  
This work suggests the possibility of a homeodomain-Wnt code that could be used 
throughout development to allow for high levels of Wnt signaling in precise expression 
domains.    
   
PRELIMINARY DATA  
Do Wnt7b and Wnt8a cooperate during heart development? 
 Preliminary work not included in the main chapters of this dissertation support the 
findings in Chapter 2 that Wnt ligands cooperate to allow for tightly controlled spatial 
and temporal bursts of transcriptional activity.  In vitro work shows that Wnt7b and 
Wnt8a cooperatively activate the STF reporter in vitro (Figure 4.1A).  Wnt7b is 
expressed in the developing lung endoderm, limb buds, and brain, while Wnt8a is 
expressed in the developing heart and hindbrain (23, 145, 146). Surprisingly, preliminary 
work on Wnt7b+/-;Wnt8a+/- double heterozygous crosses have produced compound 
mutants with cardiac defects, which is especially interesting, as a cardiac phenotype has 
not been seen in either the Wnt7b-/- mutant heart or the Wnt8a-/- mutant heart.  The 
Wnt7b/Wnt8a compound mutants have ventricular septation defects and thin 
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myocardiums (Figure 4.1B-E).  A further point of interest is that while Wnt8a is 
expressed in the developing heart, Wnt7b is not, though a thorough analysis of Wnt7b 
expression prior to E9.0 has not yet been undertaken.  The close proximity of the heart 
and lung during early embryonic development may highlight another instance in which 
cooperative Wnt signaling is utilized.  These results lead to the question: How and in 
what cell types do Wnt7b and Wnt8a cooperate during heart development?  
 
FUTURE DIRECTIONS  
A role for msh containing genes in the cooperation between Wnt2 and Wnt7b? 
 The VP16 and engrailed fusion constructs in Chapter 3 of this dissertation suggest 
that a gene containing the same, or highly similar, homeodomain as Msx1 and Msx2 is 
involved in the cooperation between Wnt2 and Wnt7b.  A potential method to determine 
a candidate list of genes would be to perform a BLAST search of the Msx1 
homeodomain sequence used for the fusion constructs.  This search would result in a list 
of genes with sequence similarity to the Msx homeodomain, which would suggest that 
they may bind to and transcriptionally affect the same targets.  To first determine if the 
candidate gene is expressed in the lung, QPCR primers could be designed and transcript 
levels measured on E10.5 – E11.5 lung cDNA.  If the gene is expressed, the expression 
pattern of the candidate could be determined by in situ hybridization, and candidates that 
are expressed in the mesenchymal compartment of the developing lung could be further 
investigated.  By determining the relevant homeodomain containing gene involved in the 
cooperation between Wnt2 and Wnt7b, the mechanism through which the 
Wnt/homeodomain interaction occurs could be further investigated. 
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Is Wnt7b acting non-canonically in this cooperation? 
 An outstanding question from this dissertation is what role each of the Wnt 
ligands has in the cooperation.  There is strong evidence from previous work that Wnt2 is 
a canonical ligand in the lung, as loss of Wnt2/2b phenocopies the loss of β-catenin from 
the foregut endoderm (4, 5).  However, the Wnt7 class of ligands is known to work both 
canonically and non-canonically (20, 33, 147, 148).  Preliminary data with chemical 
inhibitors and phorbol 12-myristate 13-acetate (PMA) indicate that the protein kinase C 
(PKC) pathway is involved in the cooperation between Wnt2 and Wnt7b, which would 
support a role for the non-canonical pathway in this cooperation (149).  However, the 
PDGF pathway also utilizes PKC signaling, which could indicate either a junction point 
between Wnt2/Wnt7b and PDGF, a downstream component of Wnt7b signaling, or a 
downstream component of PDGF signaling (150).   If Wnt7b is signaling through the 
non-canonical pathway, this would support a cooperative role between canonical and 
non-canonical signaling, which would add to the current knowledge of canonical/non-
canonical pathway interactions. 
 
What is the role of the PDGF pathway in the cooperation between Wnt2 and Wnt7b? 
 In Chapter 2 of this dissertation, the PDGF pathway is shown to play a role in the 
cooperation between Wnt2 and Wnt7b, and knockdown of the pathway in lung explants 
results in decreased smooth muscle formation and canonical Wnt signaling.  However, 
the mechanism by which the PDGF pathway is potentiating the cooperation is not known.  
The cytoplasmic domain of PDGFRs are autophosphorylated following PDGF ligand 
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dimer binding, and the phosphorylated tyrosines serve as docking sites for individual 
downstream signaling proteins.  Specific tyrosine residues have been mutated and 
characterized in mice to determine the effects of blocking specific downstream pathways 
of PDGF signaling (78, 79, 151, 152).  By using the information known about which 
tyrosines act as docking sites for effectors of the downstream pathways, we can construct 
PDGFR plasmids with the same point mutations and see which downstream pathway(s) 
play a role in the cooperation between Wnt2 and Wnt7b. 
 However, there are definite caveats to this proposed experiment.  Both Wnt2-/- 
and Wnt7b-/- single mutant mice have decreased PDGFR expression, which could mean 
that both Wnt2 and Wnt7b affect PDGFR transcription (33, 74).  As such, by transfecting 
cells with either Wnt2 or Wnt7b, wild type PDGFR may be transcribed, and may obscure 
the ability to measure any affect a PDGFR kinase mutant would have.  However, 
epithelial cells do not normally express PDGFRs and therefore an epithelial cell line will 
have less PDGFR present on the cell surface following transfection, and perhaps allow a 
greater ability to measure any effect a PDGFR kinase mutant may have. 
 If the specific PDGF downstream signaling pathway, or combination of pathways, 
supporting Wnt2/Wnt7b cooperative signaling is determined, we will be one step closer 
to determining how the PDGF pathway works in concert with Wnt signaling.  
 
Are Lef/Tcf factors being modified? 
 The work in Chapter 2 of this dissertations illustrates that β-catenin is necessary 
for the cooperation between Wnt2 and Wnt7b, but that there is not a concomitant increase 
in β-catenin nuclear accumulation.  How Wnt2 and Wnt7b cooperation results in such 
 109 
high reporter activation is not known.  Recent work on the DNA binding partners Lef/Tcf 
have revealed a method of transcriptional activation by post-translational modifications. 
 In Chapter 3 of this dissertation, I discussed a high throughput genomic screen 
that identified Pias4 as having a positive effect on Wnt2 signaling.  In data not presented 
in this dissertation, the combination of Wnt2 and Wnt7b increases the transcription of 
Pias4, as measured by QPCR.  Published work shows that Pias4 sumoylates Tcf4 to 
positively affect the TOP-fos-Luc reporter, which is very similar to the STF reporter used 
in Chapters 2 and 3 of this dissertation, except that it only contains three Lef/Tcf binding 
sites (153).  By transfecting 293 cells and keeping constant the amount of β-catenin in the 
cell, the authors found that increasing amounts of Pias4 caused stepwise increases of the 
TOP-fos-Luc reporter activity from approximately 20 to 100 fold (123).  Perhaps a 
similar mechanism is occurring in the Wnt2/Wnt7b cooperation, whereby Pias4 is 
transcriptionally upregulated by Wnt2 and Wnt7b, resulting in the sumoylation of Lef or 
Tcf, allowing for increased signaling without affecting β-catenin accumulation.     
 An additional modification of Lef/Tcf factors that affects the strength of 
transcriptional activation, or repression, is phosphorylation.  Homeodomain-interacting 
protein kinase 2 (Hipk2) functions as an on/off switch for the Vent2 gene, a Wnt target 
gene aiding in dorsal-ventral patterning of the Xenopus embryo.  Hipk2 phosphorylates 
Tcf3, which in the context of the Vent2 promoter, has a repressive function on gene 
transcription.  However, upon phosphorylation, Tcf3 dissociates from the promoter, 
allowing Lef1 to bind, and upon Wnt8a mediated nuclear β-catenin accumulation, 
activates transcription (154).  Wnt signaling also plays an important role in maintaining 
progenitor cell identity in intestinal crypts.  Traf2 and Nck-interacting kinase (Tnik) was 
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discovered proteomically to directly interact with Tcf4, and through its kinase domain, 
phosphorylates Tcf4 upon Wnt stimulation to activate β-catenin mediated transcription 
(155).  These examples illustrate possible mechanisms through which post-translational 
modifications to Lef/Tcf factors could account for the cooperation between Wnt2 and 
Wnt7b.  By performing immunoprecipitations and Western blots for Lef/Tcf 
modifications in the context of the Wnt2/Wnt7b cooperation assay, we can determine if 
there are post-translational modifications in response to expression of both ligands. 
 
Is β-catenin being modified? 
       In Chapter 2 of this dissertation, a Western blot experiment illustrates that the 
accumulation of nuclear β-catenin does not correlate to the level of STF reporter 
activation.  In addition to Lef/Tcf post-translational modifications, modifications to β-
catenin have shown increases in signal output without an increase in protein 
accumulation.  As mentioned previously, acetylation of β-catenin by p300 increases the 
affinity of β-catenin to Tcf4, and leads to increased TOPFlash reporter activation, without 
appearing to increase β-catenin accumulation (111).  Also mentioned previously, β-
catenin is phosphorylated by PKA, which can be activated in many contexts, including by 
PDGF signaling (156).  This phosphorylation leads to increased transcriptional activity, 
without affecting nuclear β-catenin accumulation (112).  Perhaps a similar mechanism is 
occurring in the cooperation between Wnt2 and Wnt7b.   To determine if β-catenin is 
being acetylated or phosphorylated in the cooperation between Wnt2 and Wnt7b, we 
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could immunoprecipitate β-catenin and perform a Western blot using antibodies against 
acetylation and phosphorylation.  
 
Possible reactivation of Wnt2/Wnt7 in pulmonary disease?  
 In Chapter 2, I described mesenchymal cell specificity for the cooperation 
between Wnt2 and Wnt7b, and also demonstrated that exogenous Wnt2 andWnt7b 
proteins in lung explants increase smooth muscle formation.  There are multiple 
pathologic conditions in the human lung resulting from increased smooth muscle 
deposition, including idiopathic pulmonary fibrosis (IPF) and pulmonary hypertension.  
In IPF, fibroblasts are recruited to sites of lung microinjuries and in an aberrantly 
coordinated repair process, cause fibrosis of the airways, resulting in a rigid network of 
fibrotic scars which restrict lung function (157).  Without a lung transplant, the lifespan 
post diagnosis is 2 to 3 years.  Of note, Wnt7b expression is increased in areas of fibrosis 
and high fibroblast proliferation, and down regulation of canonical Wnt signaling reduces 
fibrosis following airway injury (158-160).  In pulmonary hypertension, the smooth 
muscle and endothelial cell layer of the pulmonary artery thickens, resulting in decreased 
vessel diameter, requiring increased right ventricular force to maintain circulation 
through the lungs.  This increased ventricular force results in dilated cardiomyopathy 
(161).  In both published and preliminary work from our lab, there is increased canonical 
Wnt signaling and PDGFR expression in patient samples of pulmonary hypertension and 
in mouse models of pulmonary hypertension (33).   The underlying cause of both IPF and 
pulmonary hypertension is increased smooth muscle recruitment and proliferation, which 
can both result from Wnt2/Wnt7b cooperative signaling.  Therefore, perhaps in these 
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pathologic conditions, Wnt2 and Wnt7b are aberrantly expressed, and reinitiate 
uncontrolled smooth muscle growth and development. 
 
Endodermal/mesenchymal lung stem cells 
 The body of this dissertation describes a unique role for Wnt2 and Wnt7b in the 
developing lung.  The combination of Wnt2 and Wnt7b results in high levels of canonical 
Wnt signaling, in a ligand specific manner.  These data can be informative to work in ES 
and iPS cell fields studying differentiation towards specific cell lineages.  For example, 
current techniques utilize the readily available recombinant Wnt3a to serve as a canonical 
signal, thereby generalizing all activities of the canonical pathway.  However, this 
dissertation highlights specific and unique roles for Wnt ligands, and their interacting 
pathways.  The data from Chapter 2 highlights that the combined inputs from Wnt2 and 
Wnt7b act through either additional or separate pathways than simply stabilized β-
catenin.  This work suggests that future studies on progenitor cell differentiation should 
consider focusing on the use of ligands expressed in the target tissue of interest to 
facilitate timely and effective stem cell differentiation. 
 
Concluding remarks 
The work contained in this dissertation highlights a novel aspect of Wnt signaling, and a 
new role for Wnts in development.  Previous work utilizes Wnt ligands interchangeably 
for canonical activation, especially with the difficulty in isolating recombinant Wnt 
proteins.  However, the work in this dissertation demonstrates that not all canonical 
signaling, or Wnt ligands, are equal - that there are specific downstream effectors that are 
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utilized in a ligand specific manner.  Wnt ligands are broadly expressed throughout 
development, and additional Wnt ligands pairs may cooperate in a manner similar to 
Wnt2 and Wnt7b, to allow for short bursts of intense activity, tightly controlled by the 
spatial and temporal expression of the Wnt ligands.   
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Figure 4.1 Wnt7b and Wnt8a cooperate in vitro and in vivo for heart development 
(A) RFL6 cells transfected with expression plasmids for Wnt2, Wnt7b, and Wnt8a show 
that Wnt2+Wnt7b and Wnt7b+Wnt8a can cooperatively activate the STF reporter.  The 
Wnt8a-/-;Wnt7b+/- and Wnt8a+/-;Wnt7b-/- mutant mice have thinned myocardiums and 
ventricular septation defects, which are not seen in the littermate control or the Wnt8a-/- 
mutant (B-E). 
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